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Sickle Cell Disease (SCD) is an autosomal recessively inherited blood disorder that leads to a 
debilitating systemic illness. Although the disease was initially found predominantly in tropical 
and subtropical regions, SCD has now become a global health problem, due to migration of 
people from various countries with a high burden thereof. Consequently, the incidence of SCD 
in South Africa has increased dramatically over the last decade. 
This study, which constitutes a minor dissertation in fulfilment of an MSc (Med) Genetic 
Counselling degree, aimed to explore the knowledge and understanding of SCD among parents 
of affected children in Cape Town as well as identify burdens associated with caring for a child 
with SCD. Furthermore, the study assessed opportunities to improve genetic counselling services 
available to parents and explored their attitude to preventive policies. 
A phenomenological approach was used to conduct this research. Seventeen semi-structured 
interviews were conducted with the biological parent of a child attending the Red Cross War 
Memorial Children's Hospital Haematology Clinic. Participants were selected using both 
purposive and convenience sampling methods. Data collected during these interviews were 
analysed using thematic content analysis. 
Themes and relevant sub-themes were identified and grouped into three categories: knowledge 
and understanding; experiences and burdens; and attitude toward preventative policies. While 
the majority of participants had some knowledge of SCD, several misconceptions were 
discovered, often relating to participants’ prior knowledge of the disease. A number of burdens 
experienced by participants were revealed, with both practical and psychosocial implications. 
Finally, it was found that the majority of participants supported all methods of screening for 
SCD, regardless of whether they would make use of the screening services themselves. 
Findings of this study provide valuable insights on the subject of experiences of parents of 
children affected with SCD as well as the potential role of genetic counselling services. This 
study contributes towards improving understanding and subsequent services provided to 
individuals raising a child affected with Sickle Cell Disease. 
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Chapter 1: Introduction and Literature Review 
1.1 Introduction 
This research was conducted as part of the requirements for completion of the MSc (Med) 
Genetic Counselling degree, and explored the knowledge, understanding and experiences of 
parents of children affected with SCD in Cape Town. Considering the rise in patients with SCD 
in the South African healthcare context, discussed in more detail in section 1.2.6, the public 
health service will need to adapt and adjust in order to provide the necessary services. However, 
there is currently no data on what people with SCD in Cape Town experience, both with regards 
to caring for a child with SCD and in connection to the health services they receive. The nature 
of the burdens experienced by parents in South Africa have also not been previously 
investigated.  
This first chapter comprises a review of the literature on the epidemiology of Sickle Cell Disease 
(SCD), the genetics of the condition, and the clinical description thereof. The chapter will also 
consider the psychosocial burdens experienced by caretakers of children affected by SCD as 
well as various SCD screening options and how the uptake thereof could influence disease 
incidence. Finally, the review will take a brief look at SCD in South Africa (SA) generally and 
Cape Town specifically, and discuss disease frequency and available services.  Altogether, this 
chapter will serve as a background introduction for this study, which aims to explore knowledge 
and experiences of parents with children affected with SCD in Cape Town. These aims are 
introduced in more detail at the end of the chapter. 
Chapter Two describes the methodological approach used in this study, while Chapters Three to 
Five report and discuss the results.  Each of these chapters present a combination of the results 
and discussion on the findings, as grouped by subject. Chapter Six provides a summary of the 
main findings, as well as recommendations based on those findings.  
1.2 Literature review 
1.2.1 Epidemiology of Sickle Cell Disease 
Sickle Cell Disease (SCD) was initially described by a Dr Herrick, who first noted the 
characteristic sickle shaped red blood cells in 1910 (Rees, Williams, & Gladwin, 2010), yet it 
has been known in certain parts of Africa since well before the 20th century (Makani, Ofori-
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Acquah, Nnodu, Wonkam, & Ohene-Frempong, 2013). SCD is an autosomal recessive 
haemoglobinopathy, characterised by the presence of sickle haemoglobin (HbS), a haemoglobin 
variant caused by the amino acid substitution of valine for glutamic acid at the sixth position of 
the β-globin chain. This substitution is the result of a single nucleotide replacement, adenine in 
place of thymine, within the β-globin gene (Frenette & Atweh, 2007). With the β-globin gene in 
the deoxygenated state, HbS has the tendency to polymerise, distorting the red blood cells into 
the distinctive sickle shape (Rees et al., 2010).  These deformed and rigid blood cells can 
interfere with normal blood flow in microcirculation and induce ischemia in tissues distal to the 
vascular blockage.  This vasooclusion is one basis for the observed SCD complications, which 
include painful crises, susceptibility to infection, stroke, and chronic organ damage (Bartolucci 
& Galactéros, 2012), which will be discussed in more detail shortly. 
Inherited haemoglobin disorders, such as SCD, were originally most commonly found in tropical 
regions (Piel et al., 2013), such as sub-Saharan Africa and central India. This origin in tropical 
areas is most likely due to the resistance to malaria conferred by the heterozygous state 
(Chakravorty & Williams, 2014). Carriers of sickle cell trait, or those with only one copy of the 
gene mutation, have lower rates of mortality from malaria infection when compared to non-
carriers, giving them an evolutionary advantage. The sickle haemoglobin variant (HbS) seems to 
lessen the risk of infection by Plasmodium falciparum, the parasite responsible for causing 
malaria (Piel et al., 2010). Although malaria is often fatal to someone affected with SCD, the 
protection appears to work in a dose-dependent manner, which means people with Sickle Cell 
Anaemia (SCA), who are homozygous carriers of HbS, have an even lower risk of being 
infected with malaria than a heterozygous carrier (Ashley-Koch, Yang, & Olney, 2000). The 
mechanism of this protective effect is not fully understood, but is thought to include both innate 
and immune-mediated mechanisms (Rees et al., 2010).  
Whatever the cause may be, it is this protective effect that is believed to be responsible for the 
high frequency of the HbS variant (Piel et al., 2010). If carriers of the HbS variant are less likely 
to become infected with malaria in areas where that disease is prevalent, they are consequently 
more likely to reach reproductive age (Makani et al., 2013).  In fact, the HbS mutation has been 
described as the archetypal example of natural selection in humans (Chakravorty & Williams, 
2014). As a result of this, populations where malaria is or was endemic can reach HbS carrier 
frequencies of up to 40% (Modell & Darlison, 2008; Weatherall & Clegg, 2001).  
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However, even if malaria as an elective force were to be removed it would take many 
generations for the gene frequencies to fall significantly (Weatherall, 2011). Moreover, despite 
the fact that SCD originated in malaria infested tropical regions, the HbS allele has now spread 
globally (Figure 1.1) due to human migration (Piel et al., 2013). As a result inherited 
haematological disorders, or haemoglobinopathies, are now the most common monogenic 
disease worldwide (Modell & Darlison, 2008; Piel et al., 2013). 
Despite this fact, determining the exact global prevalence of SCD can be difficult, as it requires 
the accurate diagnosis and registration of all SCD affected children at birth. 
Figure 1.1: Predicted global distribution of HbS allele frequency (Piel et al., 2013). 
While this is efficiently done in countries such as the United States of America (USA) and the 
United Kingdom (UK), it is limited in African countries, which make up 75% of the global SCD 
population (Makani et al., 2013). To overcome this problem, an alternative method of 
determining disease prevalence is to use the prevalence of the heterozygous carrier state to 
calculate the expected birth rates based on the gene frequency and Hardy-Weinberg equation 
(Makani et al., 2013; Piel et al., 2013). It has been found that 5.2% of the world population carry 
a haemoglobin variant, of which 40% carry the HbS variant that contributes towards SCD 
(Modell & Darlison, 2008). Calculations made with these frequencies have estimated that 
worldwide, more than 300 000 children are born with SCD every year (Chakravorty & Williams, 
2014;  Makani et al., 2013; Modell & Darlison, 2008). 
As a result of this high disease incidence, haemoglobinopathies present a health burden 
comparable to that of communicable diseases (Weatherall, 2008). This is particularly true in the 
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developing world where diagnosis and treatment is not always readily available. The burden of 
SCD has been further highlighted by the high birth prevalence, resulting in the World Health 
Organization (WHO) recommending SCD as a public health priority in 2006 (Makani et al., 
2013). 
Moreover, as SCD can be cost-effectively controlled through programs that integrate treatment, 
carrier detection and genetic counselling, as discussed later, the WHO has also recommended 
global development of these services to combat the high disease burden (Modell & Darlison, 
2008). 
1.2.2 Genetics of Sickle Cell Disease 
Understanding the underlying genetics of SCD is vital, as genotype is the most important risk 
factor and predictor of SCD disease severity (Ashley-Koch et al., 2000), which can vary 
considerably. Genotype will be an indication of the types of haemoglobin present in the blood of 
an affected person, which in turn will be an indication of severity. 
Normal Haemoglobin 
Normal adult haemoglobin (HbA) are heterotetramers, consisting of α- and β-like globin chains, 
each carrying an iron containing molecule called heme (Figure 1.2). This molecule enables the 
protein to carry out its major function of delivering oxygen from the lungs to peripheral tissue 
throughout the body  (Thom et al., 2013).  
Figure 1.2: Structure of HbA (Mader, 1997) 
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The instructions for making haemoglobin come from the globin family, a group of genes 
involved in oxygen transport (Ashley-Koch et al., 2000). The genes found in this group are 
developmentally regulated (Figure 1.3), so that specific types of globin are present at specific 
times throughout human development (Thom et al., 2013). The type of globin (α, β, δ, γ, ε, or ζ) 
present will in turn change the structure of human haemoglobin found during embryonic, foetal 
and adult life (Weatherall & Clegg, 2001). For example, adult (HbA) and foetal haemoglobin 
(HbF) consist of α-globin chains combined with β-, γ-, or δ-globin chains, while embryonic 
haemoglobin is made up of α-like chains combined with γ- or ε-globin chains (Makani et al., 
2013; Weatherall & Clegg, 2001). 
During foetal life, HbF is the predominant type of haemoglobin present in the blood, but this 
changes around birth when a switch occurs from HbF to HbA gene expression, at which time 
HbF is gradually replaced by HbA, and by 6 months of age it is the primary haemoglobin found 
in the blood (Sankaran & Orkin, 2000; Thom et al., 2013). In a person affected with SCD, this 
replacement of one type of haemoglobin with another will mark the start of symptoms, as HbF 
will in their case not be replaced by HbA, but rather by HbS. 
 
 
Figure 1.3: HbF to HbA switch. This figure illustrates the timing of the switch from HbA to HbF. 
The top section shows the site and level of various types of globin as expressed at specific times 
during development. The colours used correspond to those used in the bottom section in a depiction 
of the developmental groups of genes found on the β-globin locus (Sankaran & Orkin, 2000). 
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Thalassemias and Sickle cell Disease  
Haemoglobin gene variants are present in all populations of the world at low frequencies, due to 
spontaneous mutations (Modell & Darlison, 2008). These mutations fall into two main groups: 
thalassemias and structural variants. Thalassemias lower the production of globin chains 
resulting in red blood cells of reduced quantity, while structural variants lead to changes in 
amino acid sequence and produces abnormal haemoglobin, resulting in red blood cells of 
reduced quality (Modell & Darlison, 2008). This is the case in SCD, where the quality of the red 
blood cell is compromised by a single nucleotide mutation in the β-globin gene, called the βs-
mutation (Ashley-Koch et al., 2000). Because of this mutation and the resulting substitution of 
valine for glutamic acid, a hydrophobic motif in the deoxygenated HbS tetramer is caused, 
leading to a bond being formed between  two β-globin chains (β1 and β2) of two haemoglobin 
molecules (Rees et al., 2010). This crystallization creates a polymer nucleus, which in turn 
causes cellular stress by disrupting flexibility and promoting cellular dehydration (Rees et al., 
2010). 
The most common form of SCD is sickle cell anaemia (SCA), which occurs as a result of the 
homozygous inheritance of the βs-mutation. In populations of African origin, SCA accounts for 
70% of cases of SCD (Rees et al., 2010). SCA, like SCD, is inherited in an autosomal recessive 
pattern. This means that in order for the disease to be expressed, two copies of the disease 
causing mutation had to have been inherited by the affected individual, one from each parent 
(Ashley-Koch et al., 2000). The primary haemoglobin present in the red blood cells of 
individuals suffering from SCA is HbS (Edwards et al., 2005).  
SCD can, however, also occur as a result of the inheritance of HbS in combination with any one 
of an extensive range of other haemoglobin mutations in individuals who are then referred to as 
compound heterozygotes (Chakravorty & Williams, 2014). In addition to one copy of the HbS 
gene variant, compound heterozygotes also carry a copy of another β-globin gene variant, such 
as haemoglobin C (HbC), which results in Sickle Haemoglobin C Disease,  or Hb β-thalassemia, 
which results in Sickle Cell/β-thalassemia (Frenette & Atweh, 2007). Compound heterozygotes 
produce a mixture of variant haemoglobins, resulting in variable disease severity (Steinberg, 
2009). 
If a person inherits only one copy of the βs-mutation in addition to one normal gene copy, that 
person is said to be a carrier. Carriers produce a mixture of HbS and normal HbA. In the case of 
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SCD, the carrier state is also often referred to as sickle cell trait. Individuals with sickle cell trait 
are not affected by SCD but it is important for these individuals to understand the reproductive 
implications (Treadwell, McClough, & Vichinsky, 2006). Children born to two parents with 
sickle cell trait have a 1 in 4 (25%) chance of being affected with SCD and a 1 in 2 (50%) 
chance of being a carrier themselves. 
In addition to genotype, a further genetic influence on SCD disease severity is the β-globin 
haplotype. A haplotype refers to a combination of DNA markers observed on a particular 
chromosome. On chromosome 11, near the β-globin gene, there is a cluster of several other 
globin genes. This region is referred to as the β-globin cluster region and as the DNA markers 
found in this region are highly variable, many haplotypes exist. However, only five of these 
haplotypes are associated with the HbS mutation, namely: Benin; Senegal; Central African 
Region/Bantu; Cameroon and Arab-Indian (Bitoungui, Pule, Hanchard, Ngogang, & Wonkam, 
2015). The haplotypes are named for the geographical regions where they were first observed, 
and because they are population specific (Figure 1.4), it is theorised that the βs-mutation arose 
independently in each of these populations (Rees et al., 2010). The β-globin haplotypes are 
associated with differences in clinical severity, which will be discussed in more detail in the 
section on pathophysiology and clinical symptoms of SCD. 
 




1.2.3 Pathophysiology and clinical manifestation of Sickle Cell Disease 
Sickle cell disease is essentially a multisystem disorder, affecting practically every organ system 
of the body (Makani et al., 2013). It is caused by an abnormality of the red blood cells that arises 
due to the abnormal amino acid found in the β-globin chain. Unlike HbA, HbS forms long, 
insoluble polymers when deoxygenated (Bartolucci & Galactéros, 2012), which causes the red 
blood cells to lose their characteristic biconcave disc shape. Instead, the red blood cells take on 
the irregular sickle or crescent shape for which the disorder is named.  
The clinical course of SCD often results in noticeable physical morbidity, as it includes periods 
of acute and chronic haematological crisis, which can at times lead to early death (Edwards et 
al., 2005). Illness severity can vary, and is associated with a range of acute and chronic health 
complications including pain crises, acute chest syndrome, cerebrovascular accidents and splenic 
and renal dysfunction (Rees et al., 2010). Makani et al (2013), divided the considerable clinical 
consequences of SCD into four categories: haemolysis and haematological complications; 
vasoocclusion; end organ dysfunction; and infection. 
Haemolysis and Haematological Complications 
Red blood cells with a sickled shape are susceptible to haemolysis, or rupturing, and show an 
average lifespan that is 6 -9 times shorter than that of normal red blood cells. This causes 
individuals with SCD to develop chronic haemolytic anaemia that will be present throughout 
their life (Rees et al., 2010). In addition to the chronic anaemia, individuals affected with SCD 
may also intermittently experience acute episodes of reduction in haemoglobin, known as an 
anaemic crisis (Makani et al., 2013). An anaemic crisis is characterized by a sudden fall in 
steady haemoglobin as well as increased reticulocytes (immature red blood cells) and 
exaggerated hyperbilirubinemia (jaundice). The latter causes a yellow discoloration of the skin 
and sclera, often seen in persons affected with SCD. While chronic anaemia itself is usually 
relatively moderate, it can lead to various secondary complications, for example gall bladder 
disease due to high levels of bilirubin. Furthermore, the presence of any viral infection can cause 
a substantial reduction in red blood cell production, which, in turn, leads to a more severe, life 





Besides the abnormal shape of the red blood cells causing anaemia, sickled cells also have a 
tendency to adhere to the walls of blood vessels, thereby clogging the vessels and preventing 
normal blood flow (Chakravorty & Williams, 2014). This blocking of the blood vessels is called 
vasoocclusion (Figure 1.5) and the resulting decrease in blood flow disrupts the flow of oxygen 
to organs and tissues throughout the body. This can often result in considerable tissue damage, 
for example acute splenic sequestration (Makani et al., 2013), which occurs as a result of sickled 
red blood cells being trapped inside the spleen. Acute splenic sequestration is clinically 
characterized by a sudden increase in splenic size, which causes reduced splenic function, and 
can necessitate the removal of the spleen. In certain life threatening instances it can also be 
associated with severe anaemia and hypovolemic shock (Chakravorty & Williams, 2014). 
 
Figure 1.5: Sickle Cell Vasoocclusion (Frenette & Atweh, 2007). 
Vasoocclusion is also thought to be the underlying cause of severe painful episodes suffered by 
patients with SCD (Edwards et al., 2005). These pain crises are considered the hallmark of SCD 
and contribute considerably to its morbidity. They are episodes of intense muscoskeletal pain, 
usually affecting the arms, legs, back, abdomen, chest and head of affected individuals (Ashley-
Koch et al., 2000; Makani et al., 2013). While it has been suggested that pain crises may be 
brought on by an increase in the ratio of sickle to regular shape red blood cells, an increase in 
barometric pressure or nutritional and stress factors (Edwards et al. 2005), the exact trigger 
thereof is usually unpredictable (Chakravorty & Williams, 2014). Pain crises are the most 
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common cause of hospitalisations among SCD affected individuals, irrespective of the numerous 
other physiological complications associated with the disease (Rees et al., 2010).  Despite this 
fact, more than 80% of pain crises occur and are managed in a home setting through caregivers 
providing medication or comfort measures (Ely, Dampier, Gilday, O’Neal, & Brodecki, 2002). 
This illustrates the extensive presence of pain throughout the lives of children and families 
affected with SCD.  
As well as being very painful in itself, these pain crises also contributes greatly to depression, 
anxiety and other psychiatric disturbances found in persons suffering from SCD (Edwards et al., 
2005). These psychiatric disturbances are frequently associated with a diminished ability to cope 
with intense pain, and in turn help continue the cycle of intensifying pain with significant life 
dysfunction and functional disability that is often marked in SCD. Because of the substantial 
chronic pain component and its impact on psychosocial well-being, it has been suggested that 
SCD is better conceptualised as a disease with psychosocial as well as physiological 
complications (Edwards et al., 2005).  
End Organ Dysfunction 
End organ dysfunction refers to damage occurring in major organs fed by the circulatory system. 
Several major organs of individuals with SCD are eventually damaged, with this occurrence 
becoming particularly evident due to increased life expectancy following suitable treatment 
(Bartolucci & Galactéros, 2012) 
Several medical complications can result from tissue damage throughout the body and includes 
delayed growth and sexual maturity; acute and chronic pulmonary dysfunction; sickle cell 
retinopathy; and dermal ulcers (Edwards et al., 2005). However, the most particularly affected 
organs are the brain and lungs. Cerebrovascular complications in SCD are a well described event 
and occur as a result of the brain being affected by obstructed blood flow. The complications can 
include temporary ischemic attacks, ischemic strokes, and haemorrhagic strokes that are 
sometimes associated with seizures (Chakravorty & Williams, 2014). Lungs are affected through 
an illness called acute chest syndrome, which is a life threatening pneumonia-like illness 
characterized by the development of new pulmonary infiltrates involving at least one lung 
segment (Rees et al., 2010). Both these examples occur frequently in persons affected with SCD 




Individuals with SCD are incredibly susceptible to bacterial infection and, in the absence of 
prophylaxis, infections are thought to be the leading cause of clinical events associated with 
increased mortality. This increased susceptibility could arise due to factors related to immunity, 
both cellular and humeral, as well as intrinsic complications of SCD or the treatment thereof 
(Ashley-Koch et al., 2000; Makani et al., 2013). For instance, end organ damage can leave 
certain sites vulnerable to infection, while chronic haemolysis leads to high bone marrow 
turnover, which results in increased vulnerability to viral infections (Makani et al., 2013). 
Furthermore, reduced splenic function (discussed above) is well known for causing immune 
deficiencies, as the spleen plays an important part in the human immune system. It has been 
suggested that by 5 years of age, 94% of individuals with SCA are functionally asplenic (Makani 
et al., 2013), thereby losing its protection against infection. All these factors contribute towards a 
significant increase in immune vulnerability among affected individuals. 
Mortality in Sickle Cell Disease 
SCD is associated with significant mortality owing to a wide variety of causes. Among children 
and adolescents, death often occurs as a result of infection or cerebrovascular incidents (Ashley-
Koch et al., 2000). Among adults the cause of mortality is more varied, and can include acute 
splenic sequestration and acute chest syndrome (Grosse et al., 2011; Makani, Cox et al., 2011) 
Irrespective of the cause, the result is a significant decrease in life expectancy among individuals 
with SCD. In the USA the average life expectancy of affected individuals is 42 and 48 years for 
men and women respectively. This is close to 30 years below that of the normal population (Platt 
et al., 1994). However, life expectancy is greatly influenced by medical care as well as 
psychosocial processes (Edwards et al., 2005), and can be considerably lower in developing 
countries. Studies done in Nigeria reported childhood mortality of up to 90% among children 
suffering from SCD, but recent estimates have suggested a decrease in mortality rates, which are 
more likely in the range of 50% by 20 years of age. This is similar to rates found in the USA in 
the early 1960s, which has since been significantly reduced with the help of early diagnosis and 




Diagnosis of Sickle Cell Disease 
Diagnosing SCD requires the analysis of the haemoglobin found in the red blood cells. In other 
words, determining the presence of HbS and the absence, or significant reduction of HbA 
(Chakravorty & Williams, 2014). The three tests most widely used for this purpose are 
haemoglobin electrophoresis, isoelectric focusing, and high performance liquid chromatography. 
All have a 93-100% sensitivity and 99-100% specificity, and can be performed on any blood 
samples, including umbilical cord blood or blood from a heel prick collected shortly after birth 
(Ashley-Koch et al., 2000).  
Alternatively, DNA testing can be performed in order to examine the disease causing mutation 
in the β-globin gene itself. This method becomes particularly necessary when no blood sample is 
available, as would be the case during prenatal testing. In such circumstances, DNA testing of 
the foetus can be done on a sample of the amniotic fluid or chorionic villus, in order to give an 
indication of whether the foetus will be affected or unaffected (Ashley-Koch et al., 2000).  
Disease Severity 
There is considerable variability in terms of disease severity in SCD and, as mentioned in the 
review on SCD genetics, genotype is the most important indicator thereof. Individuals with SCA 
are most severely affected, followed by individuals with Sickle Cell/β0 thalassemia. Individuals 
affected with Sickle Cell Haemoglobin C Disease and Sickle Cell/β+ thalassemia tend to be less 
severely affected (Ashley-Koch et al., 2000; Steinberg, 2009) 
Persons diagnosed with SCA and Sickle Cell/β0 thalassemia have a higher rate of acute chest 
syndrome and pain crises than individuals with Sickle Haemoglobin C disease and Sickle β+ 
thalassemia. Individuals with SCA also have the highest rate of cerebrovascular complications 
when compared to the other types of SCD. On the other hand, individuals with Sickle 
Haemoglobin C disease have an increased risk of thromboembolic complications, retinopathy 
and renal papillary necrosis in comparison to those with SCA. There is also a difference in life 
expectancy, with that of individuals affected with SCA being on average 20 years less than that 
of individuals with Sickle Haemoglobin C disease, most probably as a result of the difference in 
clinical severity between the two genotypes (Ashley-Koch et al., 2000).  
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Besides genotype, other factors have also been identified as associated with SCD disease 
severity. These factors include level of HbF, β-globin gene cluster haplotype, and α-globin gene 
complement (Steinberg, 2009). HbF, if present at increased levels, can result in a less severe 
clinical form of SCD. It has been found that some individuals show a genetic predisposition to 
unusually high levels of HbF. This occurs as a result of over expression of γ-globin chains in 
certain adults. However, this hereditary persistence of HbF is very rare, and while the majority 
of affected individuals have varying levels of residual HbF it is not high enough to suppress 
severity (Ashley-Koch et al., 2000; Steinberg, 2009).  
The influence of the β-globin haplotype on disease severity is due to its impact on this variation 
in the level of HbA and HbF (Ashley-Koch et al., 2000). Concentration levels of both HbA and 
HbF vary depending on haplotype, with genetic variants at three loci (BCL11A, HBS1L-MYB 
and the HBB cluster) accounting for 10–20% of HbF variation among SCD patients in the USA, 
Brazil (Lettre et al., 2008) and the UK (Thein & Menzel, 2009). Initial studies in Tanzania and 
Cameroon have also shown that single-nucleotide polymorphisms (SNP) in the BCL11A loci are 
prevalent in both Tanzanian and Cameroonian patients, with significant association of these 
SNPs with HbF (Makani, Menzel et al., 2011; Wonkam, Ngo Bitoungui, et al., 2014). Of the 
three most common haplotypes, Senegal, Benin and Central African Republic, the first is 
associated with the least severe form of SCD. This is followed by the Benin haplotype, while the 
Central African Republic haplotype is associated with the most severe form of the disease 
(Steinberg, 2009). 
Perhaps most importantly, levels of HbF is amendable to therapeutic manipulation, and certain 
therapies for SCD, such as hydroxyurea, have been developed using this principle and work by 
increasing the level of HbF in the blood of affected individuals (Sankaran & Orkin, 2000; 
Steinberg, 2009).  
Finally, among individuals with SCD, coinheritance of α-thalassemia, an α-globin gene variant, 
seems to be protective against certain disease complications, specifically acute chest syndrome, 
anaemia and cerebrovascular accidents (Hsu et al., 2003). On the other hand, this coinheritance 
increases susceptibility to other disease complications, such as pain crises (Embury et al., 1982).  
Despite this knowledge regarding the factors that can influence disease severity, predicting the 
progression and outcome of SCD from birth remains difficult (Rumaney et al., 2014). 
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Treatment of Sickle Cell Disease 
The main focus of the treatment of SCD involves clinical management of the symptoms, which 
can be divided into four approaches: supportive, symptomatic, preventative and abortive.  The 
first is the most common, and involves assuring a balanced diet, adequate hydration and 
supplementation of folic acid.  Symptomatic treatments are those targeted at alleviating specific 
SCD symptoms (Pule & Wonkam, 2014). For example, blood transfusions can relieve anaemia 
by increasing the level of normal haemoglobin present in the body and reducing the number of 
sickled blood cells in circulation (Makani et al., 2013). The preventative approach is aimed at 
prohibiting certain disease complications, and includes pneumonia and influenza vaccinations 
and the use of hydroxyurea (Pule & Wonkam, 2014).  Hydroxyurea is a cytotoxic drug that has 
been shown to be effective in reducing morbidity and improving survival among individuals 
with SCD, as well as reducing the frequency of pain crises and consequent hospital admissions 
(Makani et al., 2013). While there might be additional benefits, including increased life 
expectancy and protection against cerebrovascular disease, the use of cytotoxic drugs are limited 
to patients with a severe clinical course due to fear of possible toxic effects (Rees et al., 2010). 
The abortive approach is limited, with nitric oxide being the only accepted agent reported to 
completely stop chronic pain episodes in certain SCD patients (Pule & Wonkam, 2014). 
A possible fifth approach also exists, not aimed at managing symptoms but at curing them, the 
ultimate goal for all genetic disorders (Pule & Wonkam, 2014). Haematopoietic stem cell 
transplantation remains the only potential cure for SCD but, due to high associated morbidity 
and mortality as well as the necessity of a suitably matched donor, it is only considered when 
serious complications have occurred (Carey, 2014; Oringanje, Nemecek, & Oniyangi, 2009). 
Gene therapy is promising and future developments might include the use of induced pluripotent 
stem cells as a source of haematopoietic progenitors for gene therapy (Rees et al., 2010). This is 
not yet a reality though, and for the moment the difficulty of balancing short term treatment risks 
against long term disease complications remain a serious problem. 
1.2.4 Psychosocial burdens experienced by Sickle Cell Disease caregivers 
As mentioned above, SCD should be conceptualised as a disease with psychosocial as well as 
physiological components. The psychosocial components can be far reaching and therefore the 
effects of SCD are by no means limited to affected individuals. The role of caring for someone 
with SCD can cause personal and family conflicts, conflicts at work, trigger strain, stress, 
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embarrassment, fatigue and depression, thereby creating a burden for caregivers and impacting 
on their quality of life (da Silva et al., 2012; Panepinto, O’Mahar, DeBaun, Loberiza, & Scott, 
2005). 
A number of studies have investigated the negative impact that SCD can have on the family and 
caregivers of individuals with SCD (Brown et al., 2010; da Silva et al., 2012; Moskowitz et al., 
2007; Wonkam, Zameyo Mba, et al., 2014) and a variety of burdens have been identified, 
ranging from hospital visits that interfere with work commitments (van den Tweel et al., 2008) 
to increased marital distress (Brown et al., 2010). 
This section will discuss some of the burdens experienced by caregivers of persons affected with 
SCD in more detail as well as their impact on the quality of life of the caregiver. For the sake of 
this discussion, burden can be defined as an objective or subjective impact, pressure or overload 
on caregivers, where subjective refers to attitudes and emotional reactions related to the 
experience of caring, and objective relates to changes in the daily life of caregivers (da Silva et 
al., 2012). Quality of life, in turn, is connected to lifestyle and includes mental state, well-being 
and satisfaction of the caregiver or parent. These concepts are formed by knowledge and 
experience, through moral, religious and psychological principals as well as by social and 
cultural values (da Silva et al., 2012). Together, these concepts shape a person’s perspective of 
their own quality of life and whether it has increased or decreased in a given situation. 
In a study conducted in the Netherlands, van den Tweel et al (2008) showed that caring for a 
child with SCD reduced the quality of life of caregivers, with an increase in depressive moods 
and reductions of happiness, vitality, cognitive function and sleeping. Moskowitz et al (2007) in 
a study in the USA found that 50% of SCD caregivers studied were at risk of clinical depression, 
compared to 19% of the control group, consisting of carers of healthy children. Such mood 
disturbances may be the result of a number of things, both physical and emotional. For example, 
sleep deprivation, as a result of night-time caregiving duties, can be a contributing factor to the 
decrease in vitality and happiness of parents caring for a child with SCD (van den Tweel et al., 
2008).  
On an emotional level, the caregiver's sense of guilt and perception of how stigmatized the 
disease is can also contribute to feelings of depression (Moskowitz et al., 2007). A Kenyan study 
on gendered experiences of stigma among families affected by SCD found stigmatisation to be 
frequently associated with the attribution of cause and subsequent blaming of the mother of 
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affected children (Marsh, Kamuya, & Molyneux, 2011). As a person’s sense of guilt in such 
circumstances is often the result of complex interaction between self-assessment, beliefs about 
causality and the responses of others (Weil, 2000), a general attitude of blame towards mothers, 
such as described by Marsh et al. (2011) could make those mothers particularly vulnerable to 
depression or other mood disturbances.  
Parents or caregivers of children with SCD face a variety of potentially problematic situations 
relating to raising an affected child. These situations can be illness specific, and as such different 
from general child rearing problems faced by all parents. It can include ensuring good nutrition, 
minimizing pain episodes, managing medication and helping the child cope with negative 
feelings about having SCD, academic problems and social issues (Ievers-Landis et al., 2001). 
With regards to nutrition, research has shown that ensuring a child affected with SCD avoids 
dehydration and exhaustion is a problem that arises regularly (Hyacinth, Adeyeke, & Yilgwan, 
2013; Ievers-Landis et al., 2001). Although any parent would be reasonably worried about 
preventing these situations, parents of children with SCD are often aware that in doing so they 
could also be preventing a vasoocclusive or pain crisis. As such, these parental tasks can become 
much more time consuming and stressful, since the potential risks for significant morbidities are 
much greater than that of the average child. 
The time needed to care for a child with a chronic disease, such as SCD, can be challenging, as it 
includes both technical and non-technical care. An example of technical care would be the 
administration of medication, while non-technical care includes feeding, grooming and dressing 
(Moskowitz et al., 2007). Moskowitz et al. (2007) found that the care demands of children with 
SCD are such that approximately 1.5 hours per day is spent on illness related care alone. This is 
over and above time spent caring for a healthy child of similar age. This level of time 
commitment can also have additional consequences, impacting other parental responsibilities, 
such as care of other children, employment, household management and social activities 
(Moskowitz et al., 2007).  
Financial concerns are often associated with increased parental stress. As expected, this is also 
true in the case of parents of a child with SCD, and a Nigerian study by Brown et al. (2010) 
reported a significant correlation between stress, finances, and parental difficulty in dealing with 
episodes of SCD illness. The study further reported that reduced employability of the carer has 
been associated with caring for a child with SCD (Brown et al., 2010). This is doubtless as a 
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result of absences due to frequent hospital visits and the unpredictability of pain crisis, which 
can interfere with work commitments and have been described in a few studies (Moskowitz et 
al., 2007; van den Tweel et al., 2008; Wonkam, Zameyo Mba et al., 2014).  
There are a number of expenses related to caring for a child with SCD, of which the cost of 
treatment is undoubtedly the greatest. This particular financial burden can be significantly 
reduced by accessing government health insurance, which offers state subsidies to lighten 
parents’ financial responsibility. This service is, however, not available in all countries, 
including several on the African continent, or does not necessarily include SCD treatment. 
Fullwiley (2010) describes SCD financing difficulties in Senegal as a ‘state neglect of 
widespread diseases like sickle cell’. As a result of economic triage in that country, majority of 
available funds go to global health priorities, such as HIV/AIDS and malaria, and cost of SCD 
treatment is the responsibility of the family (Fullwiley, 2010). 
Apart from treatment, there are also additional costs involved in caring for a child affected with 
SCD, such as travelling to the hospital and loss of income through care related absences. Health 
status of a child with SCD can have a considerable impact on the socioeconomic burden placed 
on families (Wonkam, Zameyo Mba et al., 2014). 
Coping with pain is often reported by parents to be the most trying situation arising from the 
disease (Ievers-Landis et al., 2001; Moskowitz et al., 2007). Pain crises in SCD can occur 
unexpectedly, and are therefore difficult to prepare and provide care for, often leaving parents 
with feelings of inadequacy and guilt. It is not surprising that Moskowitz et al. (2007) found 
caregiving burden to be directly associated with the amount of crisis care needed by the affected 
child. Similarly, a study done in Cameroon by Wonkam et al. (2014) found that pain crises most 
undermined the coping ability of parents.  These pain crises can cause further parental anxiety by 
resulting in school absenteeism and contributing to poor academic achievement (Brown et al., 
2010; Wonkam, Zameyo Mba et al., 2014).  
The chronic nature of SCD may also contribute substantially to reduce social functioning, 
quality of life as well as alter the inter- and intra-personal relationships of patients (Brown et al., 
2010).  Parents of affected children often report daily emotional challenges, including constant 




Promoting the wellbeing of caregivers is important as this can often indirectly influence the 
quality of care given to the affected child (van den Tweel et al., 2008).  
1.2.5 Screening for Sickle Cell Disease 
Screening can be defined as the systematic application of a test to identify individuals at 
sufficient risk of a specific disorder to warrant further investigation or direct preventative action, 
amongst persons who have not sought medical attention on account of symptoms of that disorder 
(Davies et al., 2000). And while screening for SCD is encompassed in that definition, as a 
genetic condition, there are also other important points to consider. Firstly, genetic screening 
should contribute to the health of the person suffering from the condition, and not merely reveal 
risk. Secondly, it should allow carriers to make informed choices regarding reproduction and 
lastly, genetic screening should move towards alleviating the anxieties of families who are faced 
with the prospect of serious genetic disease (Davies et al., 2000).  
When implemented correctly and successfully, screening for SCD covers all the above 
mentioned points; can lead to increased awareness and education of SCD (Carey, 2014); and, 
most importantly, lead to a reduction in disease incidence (Davies et al., 2000). Screening for 
SCD is most often done at three stages: premarital, neonatal and prenatal testing. 
Premarital Screening 
Premarital genetic screening involves the detection of SCD mutation carriers and informing 
them of their risk of having an affected child prior to their marriage and/or childbearing years. 
For autosomal recessively inherited diseases, such as SCD, this can possibly be described as the 
only available form of primary prevention, as prenatal and neonatal screening are both secondary 
preventions (Memish & Saeedi, 2011). Carriers are accurately and inexpensively detected 
through routine haematological methods and can then be forewarned of their risk, which allows 
couples to make reproductive choices. These factors make premarital screening an important 
strategy to reduce disease incidence and policies implementing it can lead to a fall in SCD birth 
incidence (Modell & Darlison, 2008). 
 A recent study in Saudi Arabia reviewed the impact of five years mandatory premarital 
screening on the prevalence of haemoglobinopathies. While no significant decrease in SCD 
prevalence was noted as yet, the study did find a 60% decrease in at-risk couples over the five 
19 
 
year period, which may considerably reduce the disease burden over coming decades (Memish 
& Saeedi, 2011). Similarly, through the prevention of at-risk marriages and education on options 
such as medical abortion, premarital screening has proved successful in a number of countries 
including the USA, UK and Canada (Alswaidi & O’Brien, 2011). 
 Neonatal Screening 
The principal aim of neonatal screening is to identify newborns with SCD, which allows for 
certain early interventions such as antibiotic prophylaxis and good nutrition (Carey, 2014). The 
USA started its first newborn screening program for SCD in 1975 (Ashley-Koch et al., 2000) 
based on the belief that early diagnosis would improve morbidity and mortality. The belief 
proved to be true, with early studies reporting a decrease in infant mortality of 10% (Vichinsky, 
Hurst, Earles, Kleman, & Lubin, 1988). In recent years SCD mortality in the USA has decreased 
drastically, primarily because of early intervention, better medical care and education of family 
members (Ashley-Koch et al., 2000). Due to the success of these genetic screening programs, 
many other countries have started implementing similar programs, in the hopes of improving 
health care and outcomes of affected individuals (Makani et al., 2013). 
Although not much research has been conducted in Africa on approaches to and views on 
neonatal genetic screening for SCD, Marsh et al. (2013) in Kenya identified a few difficulties 
that might arise due to SCD screening. These difficulties included parental denial, paternal 
denial through doubts around paternity, managing incidental findings on non-paternity and 
maternal blame (Marsh et al., 2011; Marsh, Kombe, Fitzpatrick, Molyneux, & Parker, 2013). To 
overcome these problems, it is important to combine neonatal screening with genetic counselling 
and disease education (Modell & Darlison, 2008). 
Indeed, to maximise the benefit of neonatal screening, a positive SCD test result should be 
accompanied by enrolment into a health service that provides comprehensive care by a 
multidisciplinary team (Makani et al., 2013). The team should be comprised of genetic 
counsellors, nurses, social workers, paediatricians, haematologists, orthopaedic surgeons and 
internists. Appropriate advice, counselling, support and care can then be provided to parents and 





One particular challenge for couples who already have a child affected with SCD is the 
possibility that future children may also be affected, adding to the financial and emotional 
burdens already experienced by the family. A possible solution to this is prenatal genetic 
diagnosis (PND), which affords the parents the knowledge of whether the foetus is affected 
before the child is born. PND represents a type of preventative strategy, as it would allow 
parents the possibility of terminating the pregnancy or taking early precautions against 
secondary complications. This can also be done for first time parents, following positive 
premarital screening. Genetic counsellors play an integral role in creating awareness of PND and 
the availability, optimal timing, and utility thereof. 
The acceptability of prenatal testing and subsequent diagnosis and termination varies. Little is 
known about the attitudes toward PND and termination of pregnancy among parents of SCD 
affected children in sub-Saharan Africa (Wonkam et al., 2011), and while the option has been 
available in Cape Town since 2010, even less is known about the attitude of parents in SA. 
Studies have shown that parents of affected children in Cameroon show a surprisingly high 
acceptance of termination of a SCD affected foetus (Wonkam, de Vries, Royal, Ramesar, & 
Angwafo, 2014; Wonkam et al., 2011). It is unknown if this is also the case among parents in 
SA. Preliminary data from an investigation done in 2012 on the awareness and attitudes of 
parents with SCD affected children in Cape Town showed that the majority of parents (70%) 
were unfamiliar with PND. It concluded that the majority of people would accept the option of 
PND if they were to fall pregnant again, but the possibility of termination was rejected by most 
(66.6%) (Wonkam et al, unpublished data). 
The question of PND warrants further investigation, as the uptake thereof could lead to a 
reduction in mortality rate due to early intervention. Consequently, it is necessary to determine 
the knowledge and awareness of PND in Cape Town in order to plan appropriate preventative 
genetic services. 
Feelings on all the above mentioned preventative strategies often vary with social attitudes and 
can be more or less effective, depending on the religious, cultural and moral beliefs of the 
population (Modell & Darlison, 2008). The effect and success of screening relies on the choices 
made by the concerned individuals (Davies et al., 2000). Premarital testing allows for the widest 
range of choices while requiring the least amount of laboratory tests. In contrast, a prenatal test 
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gives fewer options and requires more invasive testing (Modell & Darlison, 2008). The success 
of each strategy might depend on how comfortable individuals are with the choices they provide.  
For this reason, it is imperative that screening services not only provide testing and consequent 
options, but also an explanation of all relevant information and guidance in the process of 
making an informed decision. 
1.2.6 Sickle Cell Disease in South Africa and Cape Town  
South Africa, being an area with little to no malaria exposure, originally had a low incidence of 
SCD, although prevalence differs for each ethnic group (Wonkam et al., 2012). Literature on 
SCD prevalence in the local South African populations is rare, but it has been found that in the 
mixed ancestry population of SA, several haemoglobin variants occur, HbS and HbE being the 
most common occurring at a prevalence of 1% each (Bird, Ellis, Wood, Mathew, & Karabus, 
1987). In addition to the mixed ancestry population, SCD cases have also been described in the 
South African Indian population as well as South African Caucasians not of Mediterranean 
descent (Wonkam et al., 2012). With regards to the prevalence of SCD among the African 
populations of SA, the heterozygous trait can be found among the indigenous Venda and 
Shangaan ethnic groups at a frequency of approximately 0.2% (Wonkam et al., 2012). This low 
frequency, along with the fact that the ethnic groups mentioned are two of the least numerous in 
SA, makes SCD very uncommon among indigenous African people from SA.   
The demographics of SA are changing, however, due to a redistribution of migrants from other 
parts of Africa, particularly Central Africa, where SCD is highly prevalent (Wonkam et al., 
2012). Wonkam et al (2012) found that up to 93.1% of SCD patients seen in Cape Town 
paediatric hospital were originally from other African countries. With this influx of immigrants, 
there now exists in SA a thriving cohort of adults and children affected with this previously 
infrequent disease. In Cape Town alone, the inflow of immigrants has led to an increase in SCD 
frequency of up to 400% over the decade ranging from 2001 to 2010 (Wonkam et al., 2012).  
This increase necessitated an adjustment of services offered to allow for the effective treatment 
of all affected individuals. Red Cross War Memorial Children's Hospital (RCWMCH) is a 
tertiary paediatric hospital where the Haematology/Oncology Service has developed SCD-
specific treatment guidelines and since 2009 sponsored the development of satellite clinics at 
New Somerset Hospital and Victoria Hospital, two secondary-level hospitals in the Cape Town 
metropolitan area. This adjustment is still ongoing. One suggestion made to improve care of 
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SCD patients and caregivers is that genetic counselling become an intrinsic part of their health 
care (Modell & Darlison, 2008), and the WHO lists genetic counselling as a priority intervention 
in primary prevention of SCD (World Health Orginization, 2010). While genetic counselling 
services are available at RCWMCH, not all patients are referred to or make use of this service 
and genetic counselling services do not extend to surrounding public primary or secondary level 
hospitals. 
1.3 Rationale for study 
As discussed in the literature review, parents and caregivers of children with SCD face many 
psychosocial burdens, including financial, emotional and disease related. There is a resident 
Cape Town population of SCD patients, but no understanding about the burdens they face or 
their experiences in having an affected child. It is also unclear what is known about SCD in this 
population, and how that knowledge might influence their experience.  
Further exploration into the role of genetic counselling in the care of SCD patients and 
caregivers in Cape Town is important, as this service could play an invaluable role in helping 
parents understand and cope with the initial diagnosis, as well as being a continued part of the 
support structure available to the patient and family. 
1.3.1 Aims 
In order to better attune current genetic counselling services offered to caregivers, this study 
aims to explore the knowledge and understanding of SCD among parents of SCD affected 
children in Cape Town and identify burdens associated with caring for an affected child. 
Furthermore, this study aims to discover parents’ attitudes toward certain preventative policies 
and assess opportunities of improving the genetic counselling services available to caregivers in 
Cape Town.  
1.3.2 Objectives 
 
 To conduct 15-20 interviews with suitable participants. 
 
 To investigate the participants’ knowledge of SCD. 
 




 To investigate participants’ feelings on preventative policies for SCD. 
 
The following chapter describes the methodological approach used to investigate and explore the 
















Chapter 2: Methodology 
2.1 Chapter introduction 
The previous chapter outlined the literature on the subject of SCD that served as a background to 
this study. It described how genetic counselling services could potentially play a vital role in 
improving care for individuals affected with SCD or helping caregivers manage the psychosocial 
burden better. This chapter describes the methodological framework used for this study, the 
population and sample used, participant recruitment, measurement instruments and how 
academic rigour was maintained. It will also provide an explanation of data collection and 
analysis process.  
2.2 Research design 
This study was conducted using qualitative research methodology. Qualitative studies are a form 
of research characterized by a drive towards in-depth understanding of a certain topic or 
circumstance, as opposed to being driven by the aim to generate accurate predictions (Patton & 
Cochran, 2002). Qualitative research involves an interpretive, naturalistic approach to the world, 
which means that the researcher studies things in their natural settings, attempting to make sense 
of phenomena in terms of the meanings people bring to them (Creswell, 2013). The 
understanding sought is acquired through the narration of the participants' meanings for these 
phenomena. The meanings can include the participants' feelings, ideas, beliefs, thoughts and 
actions (McMillan & Schumacher, 2001). One of the strengths of qualitative research is that it 
draws on participants’ individual life experiences and the context within which they live. 
Qualitative research is conducted when a researcher wants to gather an in-depth understanding 
of a research question (Creswell, 2013). This can be the case when literature on the topic is 
limited, or, as is the case with this study, because existing literature does not take into account 
certain characteristics of the population being studied.  Moreover, certain research questions lend 
themselves better to qualitative research, as they need to draw on people’s individual experience 
to form an answer. As this research aimed to explore personal experiences of SCD in a 
population hitherto unexplored a phenomenological, cross sectional approach was used.  
Phenomenology is an approach to qualitative research that describes the common meaning 
different individuals attribute to their experiences of a phenomenon (Creswell, 2013). It focuses 
on what all participants have in common as they experience a phenomenon. The study 
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investigated participants at a single point in time, which required the use of a cross sectional 
design. In comparison, a longitudinal study would investigate the same participants over a period 
of time. While a cross sectional study has the disadvantage of not taking into account any data 
that might change over the course of time, it has the advantage of being less time consuming. 
The latter made it an ideal approach for a minor dissertation. 
2.3 Study population and sample 
2.3.1 Population 
The majority of diagnosed SCD patients enrolled for healthcare in Cape Town are children, most 
of whom either immigrated to SA with their parents, or are first generation South Africans. Due 
to their age, genetic counselling services would not focus on these patients themselves, but rather 
on their parents or primary caregivers. For this reason, this study enrolled all consenting parents 
that presented at RCWMCH Haematology Clinic with their SCD affected child in February and 
March of 2015. 
Only biological parents were recruited, as this was the most time effective way to discover the 
primary caregivers most likely to have the in-depth experiences sought in this study. 
Furthermore, only parents who could speak English were recruited. This was done as the time 
constraints of a minor dissertation made the use of various translators impractical. However, a 
recent review of parents of SCD patients attending RCH reported only 3 out of 56 (5.3%) as 
unable to speak English. Therefore it was felt that this exclusion was unlikely to eliminate large 
numbers of possible participants. The study recruited parents of both genders, as the experiences 
of a father might be different to those of a mother. However, the recruitment strategy was to 
interview whoever brought the child to clinic, which, in most cases, proved to be the child’s 
mother. This is reflected in the final sample demographics as described in Chapter Three. 
2.3.2 Sample size  
The intent in qualitative research is not to generalize the information, but rather to elucidate the 
specific (Creswell, 2013), and given that the purpose is to acquire in-depth and multi-
dimensional data, a small, information-rich sample is sufficient (B. Marshall, Cardon, Poddar, & 
Fontenot, 2013; M. N. Marshall, 1996).  Prior to starting the interviews, and based on precedents 
by similar studies, it was estimated that a total of 15-20 interviews would be conducted, 
continuing until saturation was reached. Keeping in mind these considerations, the researcher 
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recruited 17 participants, 12 female and 5 male. The nature of a minor dissertation and time 
constraints prevented the recruitment of a larger sample size. However, it was felt that data 
saturation had been reached. 
2.3.3 Sampling method and recruitment 
Participants were selected using both purposive and convenience sampling methods. Purposive 
sampling involves recruiting participants due to certain qualities they possess and specific 
criteria that they meet (Treadwell et al., 2006), while convenience sampling involves drawing 
samples that are both easily accessible and willing to participate in a study (Teddlie & Yu, 
2007). 
The researcher attended Haematology clinics at RCH, where she was already known to the 
nurses and doctors, having previously completed 3 months clinical training there. Two members 
of the supervisory team are also involved in this clinic as medical professionals. 
The nurse running the clinic initially pointed out any eligible participants, i.e. parents who had 
brought their affected child to clinic. The researcher subsequently approached possible 
participants to inform them of the objectives and methods of the proposed study. Prospective 
participants were given an information sheet (Appendix I) to read. The researcher also used this 
initial approach to establish their proficiency in English, thereby excluding those who did not 
meet that particular inclusion criterion.  
Individuals willing to participate were interviewed at a convenient time, usually during clinic 
hours on the same day, but on one occasion by appointment at a later date.  Participant 
recruitment and interviewing took place between February and March 2015.  
2.4 Measurement instruments 
For the purpose of this research, a semi structured interview guide was used as an instrument to 
assist in data collection (Appendix II). The guide covered several topical areas, and enabled the 
researcher to explore participants' thoughts, feelings and opinions without the fear of anything 
significant being overlooked. This type of interview does not require questions to be asked in a 
particular order, but allows the flexibility for any emerging topic of interest to be discussed as 




The interview guide was developed by identifying potentially relevant themes through the 
literature review, and by examining previous guides used in similar research in other settings. 
The interview guide identified important themes for investigation, as well as a number of sample 
questions for each theme. In addition to open-ended questions, basic socio-demographic 
information was gathered at the start of each interview. The use of open-ended questions 
allowed and encouraged elaboration on the part of the participants, giving them the chance to 
express themselves freely and in great depth on those topics they considered most important. 
The interview guide included questions in the form of key words or phrases that served as a 
prompt to the researcher. These words or phrases could then be adapted into open-ended 
questions as needed. The final interview guide consisted of 24 prompts in total, divided into four 
sections: sociodemographic information, knowledge and understanding of SCD, experiences 
with SCD and preventative policies.  
In order to ensure validity of the guide the following procedure was followed in developing it: 
the first draft of the guide was critically reviewed by the supervisory team to ensure that all 
relevant questions were included. The guide was then used as a base for the first pilot interview, 
which was a role play scenario involving the student researcher and the genetic counsellor on the 
supervisory team. A second genetic counsellor and trained qualitative methodologist observed 
the interview. Following this first pilot, the interview guide was tested in a second pilot 
interview with a participant who met the inclusion criteria. Feedback and lessons learnt from 
these two pilot interviews were incorporated in the guide. It was then reviewed finally by the 
supervisory team and used for all subsequent interviews.  As the participant of the second pilot 
interview met all the inclusion criteria, she was ultimately included in the study subsequent to a 
follow-up interview to augment the data already gathered. 
2.5 Data collection 
2.5.1 Research setting 
Data collection took place at the Haematology clinic at RCWMCH, in what can be called the 
'natural setting', or the site where participants experience the problem being studied (Creswell, 
2013).  In this case the ‘natural setting’ was the setting in which they were faced with the 
medical aspects of SCD. This setting was convenient as it involved no extra travel or cost to the 
participants and interviews could often be done during time that would have been spent in the 
waiting room. While interviewing participants in their own home would have given the 
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researcher the opportunity to observe them within their home context, the logistical difficulties 
of travelling and arranging suitable meeting times made this option impractical within the 
available time.   
As mentioned, the researcher had previously spent time working in the Haematology clinic. This 
time spent in the environment was invaluable as it gave the researcher some time to observe the 
setting, possible future participants, and orientate herself in the field where data collection would 
take place. Interviews were conducted in a semi-private room due to the impracticality of 
ensuring a completely private room at all times. However, brief interruptions, when they 
occurred, were by clinic staff well known to the participants, and did not seem to impede their 
willingness to discuss sensitive topics in any way.  
2.5.2 Procedure 
There are several methods of collecting data in a phenomenological approach, from individual 
interviews to diary entries. In this study, data needed to answer the research questions was 
gathered through semi-structured interviews held with research participants. Face-to-face 
interviews are one of the most common approaches to the collection of qualitative data, as it 
allows for the detailed exploration of any personal and social matters that would not be easily 
discussed in a group setting (Dicicco-bloom & Crabtree, 2006; Sturges & Hanrahan, 2004). The 
fact that the interviews were done in person allowed the researcher to observe and note any 
nonverbal communication or behaviour that possibly added to the richness of the data. It also 
enabled the researcher to react to any cues from the participants in order to achieve maximum 
clarity on the information shared.  
All interviews were conducted by the researcher and lasted on average 40 minutes. Interviews 
were audio recorded in order to avoid excessive note taking during interviews. This allowed 
undisturbed observation and engagement between the researcher and participant. Furthermore 
recording the actual words spoken by participants allowed for re-examination of interviews 
during transcription. 
While recordings were the main source of data, there were multiple secondary forms of data in 
the shape of descriptive notes taken during the interview and directly afterwards as well as 
reflective notes developed over time while studying the data. Together, these notes are referred 
to as field notes in the remainder of this work. 
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Participants were interviewed over a period of eight weeks. Before the start of every interview, 
the researcher and participant went through the informed consent form (Appendix III), 
discussing the study objectives and matters of confidentiality. Participants were reassured that 
anonymity would be maintained through the use of unique identifiers assigned to each interview. 
This would be the only form of identification used in the interview guide, transcript and data in 
the dissertation. Personal details of the interviewees were not shared with the supervisors.   
Discussion of the consent form together with the initial demographic questions asked was a good 
opportunity for the researcher to establish a rapport with the participant, making it easier to ask 
more personal questions as the interview progressed. Following the interview, participants were 
referred to a qualified genetic counsellor when necessary or if they expressed a wish for further 
information regarding the condition. 
2.6 Data analysis 
Data generated during the interview process are so-called raw data that have no meaning on their 
own unless processed, organised and interpreted to identify important findings. This study made 
use of thematic content analysis to explore the data and identify underlying themes (Creswell, 
2013). This method of data analysis was selected as it focuses on the extraction of "content 
areas" or "coding" so as to categorize and analyse themes to create a comprehensive picture of 
an individual's experience of a phenomenon.  
In order to prepare the data for analysis, all interviews were transcribed by the researcher. This 
happened concurrently and subsequent to the interviews. Engagement in transcribing was an 
opportunity for the researcher to become familiar with the data, getting an idea of each interview 
as a whole before breaking it into parts through analysis. Listening to the interviews while 
transcribing also helped the researcher acquaint herself with the participants, their way of 
speaking and their vocabulary. All this became valuable in the form of reflective field notes to 
inform data analysis and conclusions.  
NVivo software (QSR International, 2012) was used to assist in the analysis and coding of 
transcripts. Coding the data refers to the process of reducing it into meaningful segments and 
assigning names to those segments (Creswell, 2013). This process of interpreting qualitative data 
can be differentiated further into open coding, axial coding, and selective coding (Flick, 2009). 
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These procedures can be combined or moved between in order to manage data. The process 
begins with open coding.  
In the process of open coding, the researcher explores broad themes in two indicator interviews. 
By reading through two transcripts and open coding them, a list of tentative codes was 
developed. Certain codes overlapped between the two transcripts, while new ones were created 
whenever needed to match text segments. In this manner a preliminary list, consisting of more 
than 50 codes, was created. The researcher met with members of the supervisory team, who had 
independently coded the same two transcripts. Following this meeting, the team agreed to code a 
further three interviews before a good coding matrix could be arrived at. These further 
transcripts were used to eliminate redundant codes, develop ideas about code hierarchies and 
identify emergent categories. Data from all five transcripts were then organized inductively into 
increasingly more abstract and hierarchical codes. Patterns, categories and themes were built 
from the bottom up, forming hierarchies based on relationships and combining them into broader 
categories or themes.  
Themes in qualitative research are broad units of information consisting of several codes 
aggregated to form a common idea (Creswell, 2013). Following this process, another 
supervisory meeting was held where the coding scheme was discussed and finalised. The 
resulting hierarchical coding matrix was then applied to all transcripts, including the five that 
were coded for the development of the open coding scheme. In analysing all the transcripts, 
certain codes became less important, while others emerged even more strongly as themes.  
Once all the transcripts had been analysed, each code and all the references for that code were 
printed to facilitate analysis. The researcher then studied the references, group by group, 
concurrently looking through field notes made during interviews and transcription in order to 
start forming theories about the data and how it informed the aims of the study. Creating links 
and relationships between various concepts and references, the researcher looked at how the data 
interacted and influenced one another, trying to find the larger meaning of the data. From there 
the results and discussion were written up. 
2.7 Validity and reliability 
Validity is traditionally defined as a determination of whether research truly measures what it 
was intended to measure. In qualitative research, validity can be seen as an attempt to assess the 
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accuracy of the findings, as described by the researcher and participants (Creswell, 2013).  
However, a basic problem in assessing the validity of qualitative research is how to specify the 
link between the situations that are studied and the version of them presented by the researcher. 
In this context, a position of "subtle realism" can be outlined, starting from three premises (Flick, 
2009). Firstly, the validity of knowledge cannot be assessed with certainty and assumptions 
should be judged based on their plausibility and credibility. Secondly, phenomena also exist 
independently of any claims made concerning them. Any assumptions made can only more or 
less approximate these phenomena. Lastly, reality becomes accessible across the different 
perspectives on phenomena and research aims at presenting reality, not reproducing it (Flick, 
2009). Starting from this position, validity in qualitative research becomes about how far the 
researchers' constructions (i.e., perceptions, interpretations, and presentations) are grounded in 
the constructions of those whom they studied, as well as how far this grounding is transparent to 
others (Flick, 2009). Thus, the production of data can be used to assess validity together with the 
presentation of phenomena and the inferences drawn from them. 
To increase validity in the present study, the researcher regularly met with her supervisory team 
who, through peer review and debriefing, provided an external check for the research process 
(Creswell, 2013). All methods used, as well as emergent themes, were carefully documented, 
analysed and discussed so as to ensure academic rigour and transparency.    
Reliability refers to the constancy or consistency of results obtained (Flick, 2009) and requires a 
detailed account of the decision making process so others may follow the same procedures. In 
order to ensure consistent results, all interviews were conducted and analysed by the same 
person.  
2.8 Ethical considerations 
2.8.1 Ethical approval 
Ethical approval for this study was granted by the Faculty of Health Sciences Health Research 
Ethics Committee of the University of Cape Town (FHS HREC/REF: 905/2014, Appendix IV).  
2.8.2 Consent 
Individuals meeting the inclusion criteria were approached by the researcher to explain the 
purpose of the study and gauge their interest in participating. Assurance was given that all 
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information given in the course of the interview would be kept confidential. Data would be 
anonymised and destroyed upon completion of the research. It was stressed that participation is 
entirely voluntary and would not result in any medical or financial gain. Participants had the 
right to withdraw from the study at any stage should they so wish, without incurring any 
(medical or other) repercussions.   
Prior to the start of each interview written informed consent was obtained from each participant. 
This included consent for the interview to be audio recorded. 
2.8.3 Confidentiality 
Confidentiality and anonymity were a priority in this study and maintained by the researcher 
throughout the research project. Both the recordings and subsequent transcripts were kept on a 
password protected computer, to which the researcher alone had access. These records will be 
destroyed once the research has been published. To ensure anonymity no names were used in 
transcripts, with all participants instead being assigned an identifier. These identifiers were used 
throughout when referring to a specific participant. In transcripts and quotations, anonymity was 
further sustained by referring to people mentioned by the participant by their relationship to that 
participant (her daughter, his son) instead of using names. 
Personal details of interviewees were not shared with the supervisory team unless the participant 
requested follow-up with a qualified genetic counsellor (who was part of the supervisory team). 
In that case, certain personal details were shared as well as the reason for the request for 
counselling. However, entire interview transcripts were not shared and the qualified counsellor 
did not at any time know the specific identifier assigned the individuals referred for genetic 
counselling. 
2.8.4 Risk and benefit to participants 
Risk to the participants included the discussion of sensitive and emotional topics. The researcher 
tried to be sensitive to the emotional state of the participants, ensuring any actionable comments 
were acted upon, and referring participants to a qualified genetic counsellor if needed. Despite 
being an emotional experience, there can be a therapeutic benefit to discussing one's 
understandings and experiences which may have been experienced by the participants. They also 
benefited from the opportunity to ask questions and the provision of contact details for further 
information. The long term benefit of the study is to employ the research findings to, if needed, 
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improve the genetic counselling process and services provided to parents of children affected 
with SCD in Cape Town.  
2.9 Chapter summary 
This research project focuses on parents of children affected with SCD in Cape Town and 
exploring their personal experiences and knowledge around their child’s diagnosis. This chapter 
described the methodology used to generate empirical data that would help achieve the aims of 
this study, as discussed in Chapter One. A total of 17 qualitative interviews were conducted with 
parents of children with SCD living in Cape Town. Interview data were analysed thematically to 
identify the main themes emerging from the participants’ discussion. The next three chapters 
will describe and discuss the results of this analysis, divided by subject into: knowledge; 

















Chapter 3: Results and Discussion on Knowledge of Sickle Cell Disease 
3.1 Chapter introduction 
This chapter starts with a brief description of the study participants, followed by the findings and 
discussion of their knowledge of SCD. This includes whatever participants knew about SCD 
prior to their child’s diagnosis and the different ways in which this knowledge can influence 
their current view of the illness. Furthermore, participants’ cognisance and understanding of the 
cause and inheritance pattern of SCD will be discussed, together with any assumptions or 
misconceptions that arose from this knowledge. An understanding of these misconceptions is 
important as it can help improve genetic counselling services by revealing areas of confusion.  
3.2 Sociodemographic data of participants 
All participants but one had immigrated to SA from other African countries. Majority of 
participants (n=10) were originally from the Democratic Republic of Congo (DRC). Age of 
participants ranged from 30 - 50 years and most were married. All but one of the participants 
described themselves as religious, with the majority being Christians (n=14), with two Muslim 
participants and one Jehovah’s Witness (Table 1).  
The number of children in a participant’s family ranged from one to five, with the average being 
three. Most participants (n=15) had only one confirmed SCD affected living child, but two 
participants had two affected children each. One participant was awaiting SCD test results on a 
sibling of their affected child, while another had a previous child who she now suspected had 
died of SCD related complications. All participants’ children were affected with SCA, the most 
common form of SCD.  
The majority of participants completed high school, and some had gone on to complete tertiary 
education (Table 1). Participant P12F was completing a nursing degree - the only the participant 
with any specialized education in the field of health care.  Two participants had attended, but not 
completed high school, and a further two attended only primary school. A summary of the 





Table 1: Summary of participants’ sociodemographic information. 






















P1F 39 Married Christian Secondary DRC DRC 4 1 14 
P2F 44 Single None Secondary RSA Nigeria 2 1 10 
P3F 30 Married Christian Tertiary DRC DRC 2 2 8 and 2 
P4M 34 Married Muslim Secondary DRC DRC 3 2 8 and 4 
P5F 30 Married Christian Secondary DRC DRC 3 1 2 
P6M 30 Married Christian Secondary ZIM ZIM 1 1 5 
P7M 30 Married Christian Secondary DRC DRC 3 1 5 
P8F 42 Married Christian Secondary DRC DRC 2 1 13 
P9M 43 Married Christian Secondary DRC DRC 5 1 4 
P10F 36 Married Muslim Primary Malawi Malawi 3 1 11 
P11M 50 Married Christian Secondary ZIM ZIM 3 1 13 
P12F 37 Married Christian Tertiary ZIM ZIM 2 1 7 
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P13F 47 Married Christian Tertiary Uganda Uganda 3 1 14 
P14F 38 Married Jehovah Primary DRC DRC 3 1 9 
P15F 29 Single Christian Tertiary Gabon Gabon 1 1 5 
P16F 36 Married Christian Tertiary DRC DRC 3 1 9 
P17F 42 Married Christian Secondary DRC DRC 3 1 7 
P: Participant; M: Male; F: Female; DRC: Democratic Republic of Congo; RSA: Republic of South Africa; ZIM: 
Zimbabwe 
3.3 Parents’ knowledge of Sickle Cell Disease 
3.3.1 Introduction 
In an illness like SCD, parental understanding of the disease and its causes has both physical and 
psychological value.  At a physical level, knowledge can be crucial for optimal self-management 
of the disease in order to reduce long term complications, while psychologically it can help 
improve psychosocial adjustment and adaptive coping (Bhatt, Reid, Lewis, & Asnani, 2011). 
This psychological benefit is arguably the more valuable of the two. Various studies have 
described a sense of security that comes from knowledge about a genetic diagnosis and it is often 
found to be a way of gaining control of an otherwise ambiguous situation (Long, Thomas, 
Grubs, Gettig, & Krishnamurti, 2011; Skirton, 2001). 
But, while knowledge can be beneficial, it can be equally detrimental, especially when the 
information is incorrect. A few studies have described important misconceptions that exist about 
SCD (Acharya, Walsh Lang, & Friedman Ross, 2009; Long et al., 2011), and to a certain extent 
those findings were echoed in this study. 
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3.3.2 Disease name 
All participants were asked if they had heard about SCD before their child was diagnosed. This 
was asked in order to evaluate their prior knowledge of SCD. Several participants responded that 
they had never heard of SCD before, not because they were unfamiliar with the disease, but 
because they knew it under a different name. The term Sickle Cell Disease was often one they 
only became acquainted with once they started attending clinics in SA. Marsh et al (2011) 
reported a similar unfamiliarity with the term among Kenyan families, who referred to SCD 
instead by certain names in their native languages.  
In this study, participants from DRC were generally more acquainted with the name “SS”. This 
name is a reflection of the kind of haemoglobin found in a person affected with SCA, the most 
common form of SCD. As mentioned in the literature review, individuals affected with SCA will 
have two copies of the variant HbS, commonly referred to as ‘SS’. It has become the practice of 
health care workers to refer to the haemoglobin simply as ‘SS’, or ‘CS’ (if affected with Sickle 
Haemoglobin C disease), and in many regions it appears as if this name has become synonymous 
with the disease, possibly stemming from patients’ familiarity with ‘SS’, ‘AS’ an ‘AA’ as terms 
to describe affected, carrier and unaffected individuals respectively. This concept is illustrated 
by the following excerpt from an interview: 
P3F: “We just say SS.” 
Interviewer: “And then that means the whole disease … all 
the kinds of Sickle Cell?” 
P3F: “Yes, you see, I’ll say she is SS, or she’s got SS.” 
The use of the term ‘SS’ as a name for SCD can lead to a number of misunderstandings, which 
will be discussed in section 3.3.5. 
Two participants, P4M and P9M, referred to the disease simply as “anémie”, the French word 
for anaemia. Both these participants were from DRC, where the official language is French. The 
name refers to one of the main symptoms of SCD, but as used by these participants, there 
appeared to be no way of distinguishing it from other forms of anaemia. It is unclear whether in 
using this name, the participants were referring only to SCA or if the name would apply equally 
to all types of SCD.  
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Two of the participants from Zimbabwe (P6M and P11M) also mentioned SCD as having 
different names in their community, “Sickler” and “Yellow”. The term ‘sickler’ as a label for 
someone affected with SCD has often been experienced as offensive by patients as it reduces 
them to nothing more than their disease (Alleyne & Thomas, 1994). However, participant P6M 
did not show any noticeable feelings of stigma relating to the name, even upon further probing, 
and it is possible that in certain areas the word has no negative connotation. Participant P11M 
said that where he came from, the disease was simply called “Yellow”, after the haemolysis 
related jaundice that often lead to the yellow colour of the sclera of a SCD-affected person.  
3.3.3 Prior knowledge and its influence on present perception 
Only one participant had never heard of SCD, under any name, before her child’s diagnosis. The 
particular participant, P2F, is a South African where, as mentioned, SCD is not very common 
and thus fairly unknown among the general population. Another participant had no personal 
knowledge of SCD, but had come across it in her tertiary education. The remaining participants 
all had varying degrees of knowledge about SCD even before their children had been diagnosed, 
either through a family or community member who was affected or, in the case of certain 
participants from DRC, because of the high prevalence of the disease in that country.  
While discussing this prior knowledge of SCD, it became apparent that all participants who had 
some prior knowledge of SCD had consequently developed a very negative view of what the 
disease was and what the outcome would be in terms of progression and life expectancy. For 
example, several participants shared their views about the characteristic appearance of a child 
with SCA in parts of Africa:  
P3F: “Just by looking at them you can tell that this one is a 
Sickle Cell, you don’t even have to wait for someone to tell 
you. They look sick.” 
As is illustrated by the above comment, it seems that many participants felt that SCA could be 
identified by a certain ‘look’ that children affected therewith had. Specifically they described the 
yellow eyes, distended stomach and pale skin that can characteristically affect a child with SCA. 
One participant likened the appearance to that of someone with Kwashiorkor, a form of 
malnutrition typically affecting children in tropical areas.  
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In certain cases, this ‘look’ seems to have become almost synonymous with a diagnosis of SCA, 
and as such, it is assumed children who do not look this way cannot have SCD. This can lead to 
considerable confusion for some parents, as the absence of these distinctive characteristics can 
lead to doubt when a diagnosis is given. The belief in this physical display of SCD due to prior 
knowledge was so pronounced that several participants mentioned not believing the diagnosis as 
their affected children did not have the look they expected: 
P3F: “She (neighbour) was looking different from other 
people. When you see her she was having yellow eyes, she was 
having wounds every time…  
It’s difficult for me to accept.” 
Interviewer: “Why is it difficult to accept?” 
P3F: “Because of those I have seen before.” 
The second main point arising from discussions on prior knowledge on SCD was participants’ 
expectations on disease progression. Most of the participants are from countries where treatment 
is scarce and expensive, and as a result the prognosis of SCD in these countries is not as good as 
in more developed countries, such as the USA and UK (Modell & Darlison, 2008; Weatherall & 
Clegg, 2001). 
While it is true that SCD is a chronic illness, it was also clear that most participants were 
describing an expectation of something much worse than what is typically seen in children with 
SCD in SA receiving adequate treatment. This perception among participants had been formed 
by experiences, either personal or indirect, of SCD in their country of origin. 
For instance, it was the expectation of several participants that someone affected with SCD 
would have a strikingly shortened life. Participants P10F and P17F used the word ‘lucky’ to 
describe children with SCD that survived to 5 and 10 years respectively. Participant P5F had 
the following to say on life expectancy: 
 “For me, it’s like a big disease and in Congo, people with 
this kind of disease is a huge problem. They’ve got limited of 
life. In Congo, this disease is expensive to treat, so most of the 
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people used to die at the age of twenty years. They don’t get to 
twenty-five years.” 
The idea of affected persons only surviving until the age of 25 was echoed by another 
participant, P9M, who said: 
“My son, because he is category of “anémie”, he not get age 
of 25, because that is the experience I get from my country. 
Those that have “anémie”, they just get age of 25, before 25 
they die” 
Another participant felt that affected people passed away between the ages of 14-18 years. Even 
though it is known that a high number of deaths in SCD occur at a young age (Modell & 
Darlison, 2008), average life expectancy, as reported in the USA, can be up to late forties if 
properly treated (Platt et al., 1994). In SA, while life expectancy is not as well documented, 
patients are expected to survive into adulthood, as evident by the existence of adult SCD services 
at, for example, Groote Schuur Hospital in Cape Town, which is involved in the follow up of 
more than 50 adults SCD patients.  
Data on life expectancy in the rest of Africa is similarly restricted, with estimates suggesting 
childhood mortality rates between 50-80% (Weatherall, Akinyanju, Fucharoen, Olivieri, & 
Musgrove, 2006). Recently, Makani et al (2011) conducted the first study to present mortality of 
SCA in Africa among a group of patients in Tanzania. The study reported mortality rates similar 
to those found in the USA before the use of penicillin prophylaxis, 1.9 per 100 person years of 
observation, but revealed that this was likely to be an underestimate, as the study was conducted 
at a university teaching hospital where patients had good access to health care (Makani, Cox et 
al., 2011). The highest incidence of death in that study was found during the first five years of 
life. Further evidence to support early mortality among SCD patients in Africa is the fact that in 
a randomly selected Cameroonian cohort of approximately 600 SCD patients, less than 5% were 
more than 40 years old (Wonkam, Ngo Bitoungui, et al., 2014) 
Even without exact numbers, it would seem several participants in this study had experienced 
similarly increased mortality rates in their respective countries, resulting in their expectation of 
significantly reduced life expectancy for their child.  
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Several participants expressed the hope of their child surviving beyond the years they thought of 
as normal, while others seemed more inclined to accept than hope. Examples of both these 
outlooks can be seen in the following quotations: 
P9M: “For my son, I hope they going to pass that age. Yes 
that, I believe that.” 
P2F: “I just accept it, because at the end of the day we all 
have to die. He's 10 now already. If he dies… I made peace.” 
To further express the ingrained belief of reduced life expectancy, some participants conveyed 
the views of certain people from their country that the early demise of a child affected with SCD 
was so certain that treatment became almost pointless in their eyes, as is shown in the following 
quotation describing community member’s attitudes: 
P7M: “If she is already sick you don’t have to spend a lot of 
money to treat her and all these things. You can just….you 
see.” 
A study in Ghana reported similar findings, wherein parents were encouraged to ‘wait patiently 
for the day of their child’s death’ (Dennis-antwi, Culley, & Hiles, 2011). 
3.3.4 Knowledge on inheritance of Sickle Cell Disease 
Most participants had some idea that SCD was inherited although none used the word 
inheritance. Rather the condition was described as ‘being in the family’ or ‘being in the blood’. 
This last description could be somewhat confusing, as it could also refer to the cause of SCD 
being literally in the blood. The indication that the phrase was being used to refer to inheritance 
was deduced from the context, as shown in the following quote: 
P14F: “Then he (the doctor) explained to me, this sickness it 
comes from the blood. Example, you and your husband make 
the same blood, like that.” 
About half of participants (n=8) correctly inferred the autosomal inheritance pattern of SCD, by 
stating that it is inherited from both the mother and father. In comparison, in a group of 
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Cameroonian patients, almost all participants defined SCA as a blood disorder (100%, n=130), 
inherited from both the father and mother (93%, n=120) (Wonkam et al., 2011).  
A few participants of this study did not know or were unsure whether SCD was inherited, while 
a couple of participants knew it was inherited but were unclear on the exact mode of inheritance: 
P3F: “It may come from the mom only or from the dad only or 
from both of them.” 
In two cases, participants had assumed that the disease would be inherited from the parent who 
also had family members affected. In other words, if the father had a family history of SCD, the 
disorder had been inherited from him, and vice versa. In both these cases however, it was the 
parent not present at the interview who had had the family history, and could therefore be seen 
as the ‘one to blame’ for the child inheriting it. This is one example of how knowledge can be 
manipulated, consciously or unconsciously, to lessen guilt and influence denial, a phenomenon 
that will be discussed in more detail in a Chapter Four. 
Several participants seemed to accept that as long as someone in either parent’s family had 
previously had SCD, the child was at risk of being affected.  The opposite is however also true, 
with a few participants believing that if no family members were previously affected, their child 
could not possibly be affected with SCD. 
Long et al. (2011) described similar misconceptions, such as the belief that only girls are 
affected, as individuals try to make sense of the SCD pattern of inheritance seen within their 
family. In a study among carriers of SCD, with and without affected children, Acharya, Walsh 
Lang, and Friedman Ross (2009) reported a mean score of 68% on a quiestionnaire designed to 
measure knowledge of inheritance of SCD. The difficulty in knowing and understanding the 
inheritance of SCD appears to extend to several populations. 
Explaining inheritance can be difficult, especially in cases where English is the 2nd or 3rd 
language, and the terms are unfamiliar. Doctors and genetic counsellors alike often try to clarify 
the concept of inheritance by using alternate phrases such as ‘runs in the family’. However, 
describing an inherited disease as ‘in the family’ does create the misperception that if it’s not 
previously seen in the family, it is not the inherited disease in question. This could be seen in 
this study, and is exemplified by participant P3F, who said: 
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“If it’s been inherited from someone, then in history, in my 
father’s family or my husband’s family in history, we should 
have heard someone had this disease before. On either side 
we should have known, at least, that there was someone. But 
that only started with this one” 
The belief was very strong in some participants that the diagnosis in their child must be wrong, 
partly influenced by this misunderstanding of inheritance, as family history was felt to be a 
prerequisite to being affected with SCD. In rural Kenya, misperceptions regarding inheritance 
was found to reinforce blaming patterns within families, as well as contributing to the low initial 
recognition of SCD and its cause, which were in turn associated with poor surveillance practices 
(Marsh et al., 2011). 
3.3.5 Knowledge of cause of Sickle Cell Disease 
Quite a number of the participants did not know the precise cause of SCD, although the majority 
identified it as ‘something wrong’ with the blood. Descriptions of what exactly was wrong in the 
blood varied greatly as is illustrated by the following quotations: 
P17F: “Sickle cell is about good “sanguine”. I don’t know the 
English name. It’s about the blood.” 
P6M: “It is a genetical disease, inherited genetical disease, 
that causes change of the red blood cells in my son’s 
body……The abnormal function of the red blood cells, 
sometimes, the haemoglobin is low and it gets stuck into the 
body.” 
Knowledge ranged from knowing only it had something to do with blood, right through to 
knowing it was caused by genes that lead to abnormally shaped red blood cells. Perhaps 
uniquely among similar African studies (Dennis-antwi et al., 2011; Ebrahim et al., 2010; Nzewi, 
2001;  Ohaeri & Shokundi, 2001; Treadwell, Anie, Grant, Ofori-acquah, & Ohene-frempong, 
2014), no mention was made of a possible supernatural cause for the disease. These findings 
suggest an improvement in the knowledge of the condition in sub-Saharan Africa. Indeed, SCA 
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was known in some parts of Africa before the 20th century with disease specific names that 
evoke acute, painful episodes or reincarnation beliefs (Nzewi, 2001; Onwubalili, 1983). 
Several participants, giving a bit more information on what they thought was wrong with the 
blood of a person with SCD used phrases such as ‘shortage of blood’ and ‘low blood’ to describe 
the cause of SCD. This could be a description of anaemia, which is more accurately a symptom 
of the disease, and as it causes the child to become pale can be construed as not enough blood. 
This assumption that SCD is caused by a shortage of blood could also be due to the treatment 
thereof with transfusion, as illustrated by the quotation: 
P16F: “I know that it’s because they have a shortage of 
blood, and sometimes are waiting for transfusion.” 
In addition to P6M, quoted previously as giving an almost perfect description of the cause of 
SCD, two more participants knew that the cause was related to the shape of blood cells. 
Participants P3F and P11M correctly stated that SCD was caused by abnormally shaped blood 
cells, although they were mistaken as to what exactly that shape was. P11M described it as 
follows: 
“Sickle cell means they cannot manufacture blood like this, 
because their cells are semi-circle. They are not like your cells 
which are normal, which are complete.” 
It was participant P3F who had a particularly interesting take on the abnormal shape of the cell: 
“What I understand, they say it’s when the blood cells have an 
S shape and does not allow for enough blood to run through.” 
This assumption on the shape of the red blood cells was probably made on account of the 
disorder often being called ‘SS’, or affected persons being described as having ‘SS’ 
haemoglobin and the participant having prior knowledge to that effect. This participant was 
aware not only of the abnormal shape of the blood cell, but also that the shape then leads to 
obstruction of blood vessels.  
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This was not the only incident of terms or names leading to confusion among participants. 
Another participant, P17F stated that she knew SCD was caused by children inheriting blood 
from their parents, but went on to say that both she and her husband were O-positive, and she 
does not understand how their child could be “AS” or “SS”.  
These are two examples of instances where certain terms were misinterpreted by participants and 
led to misunderstandings. In the case of participant P3F, the misunderstanding was quite 
harmless, albeit interesting. In case of participant P17F, however, there was significant 
confusion that could have been avoided if the terms were explained more clearly. ‘AS’ and ‘SS’ 
are often used by health care professionals, as they are short, easy, and often familiar. But 
familiarity does not necessarily equal understanding, and it is important that even these ‘easy’ 
terms are clearly explained and clarified to parents to avoid adding to their confusion. 
Another participant said it was possibly caused by “something in the bones”, an assumption 
most probably based on the fact that the pain occurs in the joints and bone and is a tangible 
symptom in a child affected with SCD.  
Interestingly, two patients thought SCD might be caused by malaria mosquitoes. Both 
participants knew that there was a link between SCD and malaria, and that it was found more 
often in places where malaria is common:  
P10F: “Sickle cell has, sometimes, like malaria. So maybe 
when, that time, the mosquito...” 
Interviewer: “So it comes from mosquitoes? Like malaria?” 
P10F: “Maybe, yes.” 
As discussed in the literature review, the high prevalence of HbS carriers, and consequent 
individuals affected with SCD, arose due to an evolutionary advantage against malaria. So while 
the cause and effect of mosquitoes and SCD is not as direct as this participant thinks, it does 
exist. 
3.4 Chapter summary 
This chapter discussed the participants’ knowledge of SCD on different topics related to the 
illness. It was found that prior knowledge of SCD significantly influenced parent’s expectation 
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of the disease, both with regards to its physical appearance and outcome. Often the absence of 
what certain participants thought of as a SCD ‘look’, specifically those observed in DRC where 
most participants came from, gave rise to doubts about the diagnosis. Several participants voiced 
very exact ideas on the likely age of survival of an affected person, as based on their experiences 
in their native country, all considerably less than is expected in SA.  While majority of 
participants knew that SCD was inherited in some way, knowledge about the exact pattern of 
inheritance varied, with participants drawing conclusions from their experiences of the disease. 
This sometimes led to the misconception that SCD could not be inherited without the presence 
of an affected family member, or that the disease was inherited only from the parent with a 
family history thereof. Knowledge of the exact cause of SCD was limited, with most participants 
knowing only that it was a problem with blood. A visual summary of this information is 
presented in Figure 3.1. A discussion on how this knowledge can be influenced and enhanced 
through genetic counselling will be presented in Chapter Five. The following chapter will 
discuss the findings on participants’ experiences in raising an affected child, including the 
burdens they face and the methods they employ in order to cope with their circumstances. 
 







Chapter 4: Results and Discussion of Participants’ Experiences 
4.1 Chapter introduction 
This chapter will present and discuss various aspects of participants’ experiences of caring for a 
child affected with SCD. These experiences, as described by participants, can be perceived as 
burdens to the parents, and have been divided into two groups, those with practical implications 
for the parents and those with psychosocial implications. Coping strategies and psychological 
defences employed by participants to overcome these burdens will also be explored and 
discussed.  
4.2 Practical implications  
4.2.1 Ensuring good nutrition 
The subject that arose most often as a complication of raising a child with SCD was that of 
nutrition. All participants, in one context or another, mentioned nutrition related to their affected 
child, discussing either the expense of high quality food, or the difficulty of making their child 
eat as much as is needed.  
Although persons affected with SCD do not have any special dietary requirements, studies over 
the last decade have shown the presence of micro- and macronutrient deficiency among affected 
individuals, despite adequate dietary intake (Hyacinth et al., 2013; Hyacinth, Gee, & Hibbert, 
2010). This deficiency is thought to be due to the increased nutritional demand required by the 
disorder, and could explain why children affected with SCD have a tendency toward 
malnutrition (Hyacinth et al., 2013). 
As a result of this tendency toward malnutrition, some participants described difficult 
experiences relating to ensuring nutrition in their child. Participant P8F described a time before 
her child was diagnosed as follows: 
“After the time, when he was a baby, he’s a small, small baby. 
Not eating. Most of the time he sleeping. And I take him to the 
doctor clinic and they shouting at me, why you don’t feed your 
child properly? Why you don’t treat him properly? I was so 
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surprised and I tried to explain to them, I don’t know what’s 
going on.” 
This experience, as shown by the participant’s animated language, had apparently greatly 
impacted her and she went on to describe how she always ensures her child has 100% fruit juice 
and porridge, even at times when there is no money, and she herself has to do without some 
necessities. 
Many other participants also mentioned the quality of food that they tried to procure for the 
affected child, highlighting the importance of what they call ‘nice food’. Among those 
mentioned were things like full cream yoghurt, cheese, vegetables and mealie meal (a type of 
flour used to make porridge). Many participants mentioned the benefit of ensuring good nutrition 
and hydration, stating that in their experience it improved overall health. However, while most 
realised the need for this, a few also stated the difficulty and expense of ensuring such high 
quality food at all times.  
Apart from the expense, there is another factor related to good nutrition that many participants 
experienced as problematic, namely implementing it. Many participants indicated that their 
affected child is often unwilling to eat, as illustrated by the following quotations: 
P11M: “The hardest part is the way it... he doesn’t want to 
eat, and you will be forcing every day. He doesn’t feel like 
eating anything, he just eats a little bit and says he’s all right. 
And if you don’t eat and drink enough water, for them, it 
becomes a problem. But he doesn’t want to. You can’t force 
him to eat. There is nothing you can do.” 
P14F: “Sometimes you give them something with the diet. For 
the tablet, you see. And I can shout, drink, this is your life. If 
you don’t drink this you going to die. It’s difficult.” 
Both participants quoted above, and others, came across the same dilemma, with regards to 
forcing a child to eat when they are unwilling. Participant P11M had come to the conclusion that 
nothing could be done without upsetting the child unnecessarily. 
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Judging by the intensity of her statement, participant P14F seems to experience this problem on 
a much deeper level. This could be as result of the severity of her child’s condition, or her own 
perception thereof. It is clear that she is very aware, on a daily basis that her child could die at 
any moment. “Thoughts of death at any time” was reported by 55% of Cameroonian parents 
with SCD-affected children as occurring “frequently or all the time” (Wonkam, Zameyo Mba et 
al., 2014). Such frequent mindfulness of the possibility of death might have a negative 
psychological effect, not only on a parent, but also the child. 
This participant’s quote illustrates one other fact about nutrition shared by a few others: ensuring 
the child eats before taking their medication. A number of participants mentioned that they 
found their child to be less likely to suffer from side effects if they take their medication after a 
meal. This direct correlation between eating and health serves to intensify the burden 
experienced by participants around ensuring and enforcing good nutrition, despite the cost 
thereof.  
4.2.2 Financial stressors 
In addition to the cost of high quality food, there were several other factors contributing to the 
financial burden experienced by participants. While the cost of having a child affected with SCD 
has been well described (Brown et al., 2010; Ievers-Landis et al., 2001), it has not been done in 
the South African health care context. Many participants described one significant factor that 
influences the cost of having an affected child in SA when compared to their country of origin. 
That is the fact that treatment in SA can be accessed through state hospitals, and the cost thereof 
is covered by a national health system. Through this national health system, treatment is 
available whenever it is needed, and patients are then billed a percentage of the cost according to 
their income. This is different from the arrangement in, for example Zimbabwe, as described by 
participant P11M: 
“There is a great difference, because you see, the medication 
in our country, sometimes I need to pay it there. If I don’t have 
the money he won’t get treated. But here he can be treated 
and I can pay you later on, when I have got the money. So 
unlike here, if my medication is finished, I come and take. And 
I can come and pay half of that money, or just a little bit, and I 
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carry on. So as much as I can afford for that time. But they 
don’t stop me from coming here with the boy.” 
This quote shows not only the difference in health care systems, but is also a practical example 
of the economic support described by many of the participants as a crucial advantage of South 
African health care. Several participants from DRC also described SCD as being ‘very 
expensive’ in their native country, while being significantly less so in SA. Nevertheless, even 
though cost is subsidised and can be paid over a period of time, it is still an extra expense to be 
planned and provided for.  
Furthermore, although treatment is fairly inexpensive, there are many other aspects of having an 
affected child that can be very costly. For example, patients need to be brought to hospital 
frequently and the commute can be expensive, as it often involves the use of public transports 
such as taxi’s or buses. Depending on where participants live in relation to the hospital and how 
often the affected child needs to come to hospital, this can become a considerable expense. This 
is illustrated by the following quotation: 
P17F: “I don’t have money, you see. Like, there are nights, I 
don’t have money, so I must soothe him until morning. It was 
so difficult for me, because any time he get sick, so if you 
don’t have money and if it’s really late…” 
This describes not only the perception of travel cost as great, but also illustrates how cost of 
travel can have a negative impact on the health of the child, resulting in him or her being 
hospitalized later than is prudent. After a number of experiences such as described above, 
participant P17F ultimately decided to relocate to within walking distance of RCWMCH, where 
she now has easy access even at night. 
A less direct financial stressor related to an affected child is the resultant loss of income due to 
missing work. Reduced carer employability in the case of a SCD affected child has been 
described before (Ievers-Landis et al., 2001), and seems to be supported in this study by a 
statement made by participant P2F: 
“At the beginning I was working, but now when he got so sick 




Participant P2F was the only participant in this study that directly related her son’s illness to her 
being unemployed. However, she is also one of only two participants in this study who is 
unmarried, and therefore solely responsible for the care of said child.  
Previous studies, discussed in the literature review, revealed many instances of loss of income 
due to missing work (Brown et al., 2010; Moskowitz et al., 2007; Wonkam, Zameyo Mba et al., 
2014). However, as many participants were unemployed, it did not emerge as a strong theme in 
this study. Still, it cannot be denied that many participants felt a significant financial burden, 
possibly intensified by the high level of unemployment.  It is perhaps best summarised by the 
following quotation by participant P2F: 
“I’m still coping. But it does make…there’s a hole, like a big 
hole in the pocket.” 
4.2.3 Caregiving time 
As discussed in the literature review, caring for a child with SCD can be time consuming 
(Moskowitz et al., 2007). This was experienced and described by participants in this study in one 
of two contexts: those who were employed and found working and having a chronically sick 
child challenging; and those who found everyday parenting tasks more time consuming than 
with healthy children. 
In the few cases where both the participant and his/her spouse were employed full time, the child 
would be sent to school, when possible, or left in someone’s care. Both these solutions were at 
times found to be less than ideal by the participants. Schools would often phone parents to 
collect their child at the first sign of illness, disrupting their work day, while the second 
possibility is hampered by the fact that the participants in question had no family in Cape Town 
to whom they could entrust the child’s care. Participant P17F depended on her eldest child to 
help look after her affected sibling, an option not available to all, and very reliant on the 
vigilance and capability of the sibling.  
Then there are the daily tasks that become more demanding when one’s child is affected with 
SCD. A previous section already discussed the difficulty of making an unwilling child eat, but 
this problem can also have time implications. Participant P10F described having to cook 
‘special’ meals for her child, both because she is more likely to eat the higher quality food and 
because it is too expensive to make it for the entire family. In the same line, participant P4M 
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described the struggle involved in getting his affected children dressed for school, with him 
wanting to ensure they are sufficiently warm and protected against infection, and the children 
becoming upset at being forced to dress differently from other children. 
Even in the case of a parent being available at all times, participants found that the caregiving 
time involved made it difficult to give equal attention to household tasks, the affected child, and 
other healthy children. This last is illustrated by the following quotation: 
P4M: You see, (daughter) can get sick, but I can’t be worried 
much. But he, when he get sick, I am worried too much. It’s 
like I don’t even…It’s like I just try to… you see…” 
As seen in the above quotation, participant P4M found it very difficult to express himself on the 
subject of his healthy daughter receiving less of his attention during an illness than one of his 
affected children. These feelings can contribute to the considerable emotional burden of having a 
SCD affected child, which will be explored in the next section. 
4.3 Psychosocial implications  
4.3.1 Emotional burden 
The emotional burden experienced by parents of children affected with SCD can be caused by a 
number of factors associated with the disease, some of which were discussed in the literature 
review. In the case of this study, uncertainty was a great contributor to parental emotional 
distress, both in terms of prognosis and the unpredictable nature of the illness.  
As an illustration of the first, several participants mentioned their fear of an uncertain future with 
their child. Many revealed a constant awareness of the possibility of their child dying, and at the 
same time conveyed an inability to come to terms with the possibility thereof. Consider the 
following quotation of participant P14F: 
“I’m very stressed, really, because I don’t know what is going 
on. I think who is going to help me with my child? I’m 
worried, one day, this blood, maybe one day it is going to 




As shown by this quotation, the uncertainty can be influenced by several things. In the case of 
participant P14F, confusion about treatment played a part, as she was concerned about blood 
being for transfusions ‘running out’. She expressed further anxiety at being unsure of her present 
situation and her daughter’s unclear prognosis. While it is impossible to accurately predict the 
future of a child with SCD, this is also true of a healthy child. This mother, and those like her, 
might benefit from some general information about the prognosis of SCD. Even if the 
information contains bad news, such as the expected reduced life span, it can still be valuable by 
removing some of the ambiguity felt by the participant. Baldwin and Carlisle, as cited by Atkin 
et al. (1998) found appropriate information was able to facilitate coping in parents, as it helped 
them make sense of the condition (Atkin, Ahmad, & Anionwu, 1998).  
Something else that caused considerable emotional distress among participants was the 
expectation and occurrence of pain crises. As pain crises occur randomly they cannot be 
prepared for, and this was described as being very unsettling and the cause of much instability in 
everyday life. In addition to this disruptive quality, pain crises were described by many 
participants as one of the most challenging aspects of the disorder to witness and handle on an 
emotional level. This was also found in a Canadian study on mothers of SCD affected children, 
where all participants reported constant fear of their child’s sudden hospitalisation or possible 
death. The study further reported participants feeling a lack of control over their everyday life 
due to the unpredictability of pain crises, leaving them with a persistent feeling of helplessness 
(Burnes et al,. 2008). Participant P4M, recalling his feelings during a crisis, gives a sense of this 
helplessness and hopelessness in the following quotation: 
“We just don’t feel to…to do… anything. We don’t feel 
like…like we just feeling nothing is better in this world. I 
can try to explain, you just feel like we have something…we 
carrying something. A heavy staff that we don’t know how to 
pick up. So we just carry that heavy staff and then we don’t 
know who can help. We just feel this staff is very heavy to us, 
but still we must have hope, maybe we going to get help.” 
Participant P11M said that he often wished he could be the one who was suffering from pain in 
his child’s place. Other participants had similar feelings, citing their inability to relieve their 
child’s pain as ‘the hardest part’ of having an affected child. In a recent Cameroonian study, pain 
crises were found to be the SCD disease related stressor that most undermined the coping ability 
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of caregivers, with the unpredictable nature of the crises possibly contributing to the perceived 
burden thereof (Wonkam, Zameyo Mba et al., 2014). Participant P11M, quoted above, went on 
to describe the ‘suffering’ as now being part of their everyday life, and something that both he 
and his child will have to come to terms with eventually. 
Contributing to feelings of hopelessness was the incurable nature of SCD, causing a few 
participants to liken it to other ‘incurable’ diseases: 
P17F: “There’s no healing. Like for malaria, the malaria is 
finished. But not for this one, understand? It’s like cancer, it’s 
like HIV. It’s the same because it’s not healing… I have no 
peace in my heart. You know they are to leave you.” 
All the factors discussed in this section can add considerably to feelings of anxiety, distress and 
depression. In order to overcome or manage these feelings, many participants adopted various 
coping styles and psychological defences, which will be discussed in section 4.4. 
4.3.2 Stigma 
Stigma is defined by the Oxford Dictionary as a mark of disgrace associated with a particular 
circumstance, quality, or person. In the case of this study, the circumstance would be having a 
child who is affected with SCD. Stigma with regards to SCD has been reported before, and often 
stems from uneducated ideas of SCD, such that it is contagious or a curse (Burnes et al,. 2008; 
Anie & Green, 2012). In this group of participants, the majority had not experienced any stigma 
related to having an affected child, although those who had, had found it to be a deeply 
distressing event.  
As SCD is a fairly unknown disease in most South African communities, it is not surprising that 
most participants had never felt judged for having a child affected with it. In fact, several of the 
participants who had experienced stigma found it to be unrelated to SCD specifically, but rather 
a result of community members noticing that the child was constantly sick. This led them to the 
conclusion that the child, and therefore likely the parents, were HIV positive.  
An example of this can be found in the following quotation: 
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P4M: “People have to talk. Some people they think maybe 
HIV. You try and explain them, they will not really understand 
it. They will think you are bringing other stories. So it is not 
easy to be in this kind of business.” 
Being HIV positive in SA still carries significant stigmatisation (Skinner & Mfecane, 2004), and 
it would appear that judgement also extends to other ‘unfamiliar’ illnesses. A few participants, 
including P4M, had found that the frequent clinic appointments and hospitalisation of their child 
was presumed by community members to be a result of them being HIV positive. As also 
illustrated by the quote, most found it unhelpful to deny or correct these assumptions, as it was 
commonly interpreted as evasiveness due to shame about their HIV status. 
In an isolated case of stigma experienced by one participant, the object of judgement was once 
again not SCD itself, but rather the treatment thereof. Participant P17F had been told that blood 
transfusions were unnatural, and that her child was ‘a dead person, not a child’. Both these 
instances of stigmatisation could be resolved or reduced through community education to create 
awareness of SCD.  
Those participants who had experienced censure related more specifically to SCD seemed to 
have encountered it mostly among individuals who had some experience of SCD, for example 
family members or individuals met in their country of origin. These individuals often had 
knowledge and exposure to SCD, and therefore were prejudiced against it. Some examples of 
judgement are described in the following quotation: 
P7M: “You see, many people, if you got a child with SS, they 
are going to laugh at you, you understand. Because many 
people they put in their minds that the child is going to die. 
When they see your child they got SS, they say ‘ah this child, 
she is not going to last. She is going to pass away. She is 
going to die’. They always think about these things. And 
already they putting something in your mind. Like you knew 
this person, she is going to pass away one day, you don’t have 
to call us and worry about, if she sick. If she is already sick 
you don’t have to spend a lot of money to treat her and all 
these things. You can just….you see.” 
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Similar experiences were described by other participants, also related to the expectation of the 
early death of his affected child. The infrequency of these events make them no less distressing, 
and one participant ultimately estranged herself from those members of her family who had 
‘given her pain’ because of her child having SCD. 
4.3.3 Support 
A good support system can often help reduce the emotional, and even financial, burden 
experienced by caregivers of children with SCD (Brown et al., 2010). Unfortunately, when 
participants spoke of social support, it was mostly to comment on their lack thereof. In a few 
cases, this was a direct result of having an affected child. 
In the case of participant P15F, the relationship she had had with her child’s father was ended 
after they realised the risk of having more affected children. She is now a single mother who had 
the following to say when asked about how she copes on her own: 
“I never discuss about… Even at school my friends don’t 
know, I don’t discuss about that. I’m not feeling free to talk 
about that. I don’t want to put it in my head, I get sick. 
Otherwise, I’m also going to fall down.” 
She went on to say that emotional strength is essential if you have a child with SCD. Her 
dependence on her own strength was partly brought about by the fact that she has no family in 
SA, and no one she could feel ‘free’ with.  
As almost all participants were originally not from SA, absence of familial support was a 
common occurrence. Moreover, a few participants felt that they would be unable to return to 
their country, and family, as they would be unable to afford the same level of care for their 
affected child. As previously discussed, SCD treatment at state hospitals in SA is inexpensive, of 
a good quality and readily available (Wonkam et al., 2012). This benefit was considered worth 
staying for, even by those who had not intended to. It was well put by participant P10F, who 
when asked if she ever thought about returning to Malawi replied: 
“I can’t. I need, but I can’t. Always very difficult being here.” 
Family is, of course, not the only source of social support. A few participants mentioned friends 
as ‘helping out’, but would go on to say that they did not feel comfortable telling friends of their 
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child illness. Often participants had no support in managing their child’s illness other than that of 
their spouse. Fortunately, in the majority of cases, participants described their spouses as being 
extremely supportive. This was very well expressed by participant P4M: 
“We need support, because we decided we have to be one. We 
have to be one, with these kids. I’m her counsellor, she’s my 
counsellor.” 
However, to increase the support available to participants, other support structures could be put 
in place. There is currently no support group active in Cape Town, or SA, for parents or 
individuals affected by SCD, but they have proven to be very successful in alleviating emotional 
and psychosocial stress and now play an integral part in the SCD care programs of the USA and 
UK (Dennis-antwi et al., 2011; Dennis-antwi, Dyson, & Ohene-Frempong, 2008). The forming 
of such a group in Cape Town could benefit many participants in this study and others like them 
by giving them much needed support as well as the opportunity to share their experience with 
others going through a similar situation. 
4.4 Coping with Sickle Cell Disease 
Given the emotional demands of raising a child affected with SCD, parents employ a variety of 
methods to help them cope with their child’s diagnosis and disease. Understanding these 
methods, utilising its strengths and minimising any threats to it, can help improve the support 
services provided to parents in similar circumstances (Atkin & Ahmad, 2000). This section will 
explore and discuss the coping strategies and psychological defences employed by participants 
in this study. 
4.4.1 Coping strategies 
Coping strategies are employed for problem solving or to change the meaning of what is being 
experienced (Uhlman, Schuette, & Yashar, 2009). Often, when the stressful situation is 
unchangeable, as in the case of a chronic illness like SCD, coping strategies tend to be more 
emotion focused, rather than problem solving (Weil, 2000). This was found to be true for most 
participants. 
As an example of an emotion focused coping strategy, many participants used religion to help 
them manage their circumstances, describing it as giving them the strength and ability to cope 
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with their child’s diagnosis and illness as well as providing a source of hope. Atkin and Ahmad 
(2000), in a study on parental coping with haemoglobinopathies, found that religion was a key 
resource in helping parents cope with the diagnosis and symptoms of SCD. In this group of 
participants, where many had no family to offer support, many turned to God as their main 
source of strength and emotional support. 
Some benefits of religion as a support structure are illustrated in the following quotations: 
P14F: “You can’t help me every day. Only God can help me. 
Jehovah he give me strength.” 
P4M: “We always put our hand in God, and put our children 
in God, because the doctor just only do what he learned in 
school, but God he will give everything after doctor finish.” 
P8F: “I have also pray to God, God must give the doctor 
more and He must also help my child. You know what I like to 
say, God mustn’t disappoint me for my child.” 
The first quotation highlights the very important fact that God is the only support available at all 
times, a very valuable quality when it comes to a disorder such as SCD, which can present with 
problems at any time. 
The last two quotes, while showing the trust the respective participants had in God also 
demonstrated something else: the importance of religion in conjunction with other coping 
strategies. In this case the more problem solving focused strategy of embracing the medical 
model. Embracing the medical model is defined as the acceptance of the medical definition of 
the disorder and using this information as a means to acquire some control over the situation 
(Atkin & Ahmad, 2000). Both participants, P4M and P8F, quoted above relied on both religion 
and medical expertise to take care of their child, using one to strengthen the other. 
However, this conjunction of strategies was not found in all participants, with many using 
religion as a means of escape-avoidance. Escape-avoidance as a coping strategy was identified 
by Lazarus in 1991 (Uhlman et al., 2009) and is summarized by Uhlman et al (2009) as hoping 
for a miracle. For many participants, relying on religion had surpassed merely drawing strength 
and support from God, as is evident from the following quotations: 
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P17F: “I know God will heal him, God is able to do 
something for him, I know that. God will do something. I 
believe in Jesus’ name. It is so painful….I know God is going 
to change his blood.” 
P5F: “God will change everything. Because this disease, I 
don’t like it. I said, God, there is no sickness or disease He 
cannot heal. That’s why I asked God to please intervene for 
me in this. I believe in God to intervene. Nothing is impossible 
for Him, because I can’t accept it.” 
Some participants, those quoted above included, clearly hoped for their child to be miraculously 
healed. While this hope is understandable and normal under the circumstances, some participants 
seemed to expect it with a worrying naiveté. The complete disregard of any other source of hope 
could lead to continued disappointment as the child fails to be healed, and in the long run could 
even cause the participants to question their faith.  
4.4.2 Psychological defences 
It’s difficult to separate coping strategies from psychological defences, as they are closely 
related. There is however one significant difference. While coping strategies involves conscious 
activities that aim to reduce emotional distress, psychological defences are an unconscious 
mental process by which painful or unacceptable realities are kept from reaching consciousness 
(Weil, 2000). Psychological defences are essential for maintaining healthy mental functioning. 
While there is no universally agreed upon list of psychological defences, some are commonly 
accepted and well defined (Weil, 2000). Denial is one of the most universally experienced forms 
of psychological defences, and was also found in a substantial number of participants in this 
study. As described by Uhlman et al (2009), denial is the inability to acknowledge to oneself 
certain information. It is a common response when the information, in this case a diagnosis of 
SCD, elicits shock and fear. When it occurs at an appropriate intensity, denial can keep 
individuals from being vulnerable to serious psychological harm, but, because denial in essence 
distorts perception of reality, it can contribute to psychological dysfunction when overly strong 
and rigid (Weil, 2000). The following quotations illustrate two examples of denial: 
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P9M: “And let me tell you the truth, at first, when they notice 
that (referring to son having SCA), I didn’t believe them. I 
didn’t believe that.” 
P3F: “I don’t really believe in it. And I’m not angry for that 
and neither sad for that. I just don’t believe in it.” 
The first participant quoted experienced denial upon first finding out about his son’s diagnosis. 
The shock of an unexpected diagnosis as well as the imminent loss of the ‘healthy child’ resulted 
in a temporary disbelief of the information provided. But denial is usually short term (Uhlman et 
al., 2009) and in the case of participant P9M, as well as a few others, he came to accept the 
diagnosis after a time, assisted by a genetic counselling session. 
However, as can be seen in the second quotation, this was not the case for all participants 
experiencing denial, and in a few, the denial was persistent and seemed to have reached a level 
bordering on dysfunction. Even after several years, participant P3F (previously quoted above) 
maintained her disbelief in the diagnosis: 
“All I think is one day it will be proven wrong. Because I 
don’t believe it is inherited, I don’t believe it. I will never 
believe it at all. Not, like, not believe in this sickness, but 
believe that my kids are sickle cells.” 
This continuous denial can have a harmful impact, not only on the person experiencing it, but 
also others in the family. In the case of participant P3F, it had already led to some disagreement 
between her and her husband, as he believed they should be focused on finding a solution or cure 
for their children’s illness. Her failure to acknowledge some aspect of the reality apparent to her 
husband has seemingly distanced her from the only support she had. On the other hand, the 
denial had resulted in no apparent harm to her two affected children. At the time of the 
interview, both were being treated only with folic acid and prophylactic penicillin. This 
treatment was normalised by the participant through saying that anyone can take antibiotics and 
vitamins, in the same way that all children can develops fevers. She did not perceive either the 
treatment or symptoms as being proof of a SCA diagnosis.  
It is important to note that in this group of participants, denial was often reinforced by their prior 
knowledge about SCD. While it is natural to make assumptions based on available information, 
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as discussed in Chapter Three, the information, as inferred from experiences in their native 
country, is not always accurate or relevant to a South African context.  Consider the following 
statements: 
P17F: “I heard, in the Congo, that people have Sickle Cell. 
The way they look, not like my baby…I told them they are 
lying. He didn’t look sick. No, they are lying, they didn’t check 
nicely.” 
P9M: “I didn’t believe, because if I saw my son and compare 
with all the kids from my country, I can see, like, the hair 
looks like my hair, not like the one from my country. But then I 
did get counsel here and I could understand everything.” 
P3F: “If it’s been inherited from someone, then in history, in 
my father’s family or my husband’s family in history, we 
should have heard someone had this disease before… And in 
my country, when we look at kids who have Sickle Cell 
Disease, they don’t look as healthy as these ones. They look 
sick, they are forever sick.” 
These participants, and others, expressed an unwillingness to believe the diagnosis because their 
child did not look as they expected a child with SCD to look. There are a few explanations for 
this difference in appearance. In the case of some participants, a diagnosis was made at a very 
early age, before the child had displayed any symptoms for a long period of time. But, in most 
cases, children were receiving optimal treatment, something not achieved in all African 
countries. As a result of this treatment, the children appeared, to the non-specialist eye, to be 
reasonably healthy and unaffected by SCD.  
In addition to this difference in appearance, participant P3F’s quotation illustrated another point 
where prior knowledge can be misunderstood and used as an argument against the diagnosis. 
This was the misunderstanding of the pattern of inheritance of SCD. While participant P3F knew 
that SCD was an inherited disorder, she assumed that it could only manifest if someone in the 
family had previously been affected. This belief was shared by a few other participants and led 
not only to a disbelief of the diagnosis, but also distrust in the doctors or health care workers 
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who were insisting the diagnosis was correct, without explaining how this was possible without 
an affected family member. 
Prior knowledge can be so ingrained that in few participants it seemed to lead to what could be 
described as a confronting coping strategy. This is summarised as a strategy whereby a person 
tries to change the opinion of the people in charge (Uhlman et al., 2009). At the time of the 
interviews, participant P3F was in the process of pursuing private SCD carrier genetic testing for 
herself and her husband. Despite the cost, she felt if she could bring the results to RCWMCH it 
would prove her belief that the doctors were wrong in their diagnosis. This challenging and 
almost antagonistic approach would need to be handled in a sensitive and effective manner to 
avoid any detrimental effects, to both the parent and the child.  
4.5 Chapter summary 
This chapter presented the findings on the burdens experienced by participants of this study in 
regards to raising and managing a child with SCD. The expense and/or effort of ensuring good 
nutrition was cited by all participants, while the financial strain and that of caregiving time 
varied according to personal circumstances. The emotional burden experienced was intensified 
by the uncertainty of the prognosis, as well as feelings of helplessness, especially during pain 
crises.  Further contributing to their burden of raising an affected child was the fact that the 
majority of participants had limited social and emotional support. Possibly as a result of this, 
religion was found to be an important mechanism for coping in this group of participants. Other 
coping mechanisms were also discussed as well as psychological defences, in particular 
examples of denial. Figure 4.1 provides a visual summary of these findings. The following 
chapter will explore the role that genetic counselling did and could play for participants, as well 
as their attitudes towards screening services. 
 
Figure 4.1: Summary of findings on burdens experienced by participants 
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Chapter 5: Results and Discussion on Screening and Genetic 
Counselling  
5.1 Chapter introduction 
This chapter will describe participants’ opinions of the screening available for SCD, including 
their attitudes towards the termination of an affected pregnancy. Finally, this chapter will look at 
the participants’ experiences of genetic counselling, the value, if any, they gained from it, and 
the opportunities for improving this service at RCWMCH Haematology clinic.  
5.2 Sickle Cell Disease screening 
In order to reduce the prevalence of SCD, many countries have started using various screening 
policies that could lead to decreased numbers of affected individuals. The screening is aimed at 
identifying at-risk couples, affected newborns, and affected pregnancies. While all these services 
are available in Cape Town, data on the practice and application thereof are scarce. A study done 
in 2012 found that while PND had been available in Cape Town since 2010, the uptake thereof 
was poor (Wonkam et al, unpublished data). Before implementing any policy it is important to 
know how the individuals it concerns would respond, and to that end participants were asked 
their opinion on premarital, neonatal, and prenatal screening. 
5.2.1 Premarital carrier screening 
Most participants (n=12) agreed with the idea of premarital carrier screening, on the basis that it 
could give one the possibility of a better future: 
P16F: “To have a better future. Instead of having children 
who may be sick, it is better to have a better future by 
preventing it in all the ways we possibly can.” 
This quotation is a demonstration of the feelings of almost all the participants who agreed with 
premarital screening. One participant felt it would be dependent on a specific couple, and what 
they would do with the information gained from a screening test. Those few who disagreed with 
the principle of premarital screening did so because they thought it would be wrong to let 
something like SCD carrier status influence a relationship. This was neatly described by 
participant P2F who said: 
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 “You can’t help who you fall in love with.” 
One participant offered the interesting opinion that premarital testing would not have benefited 
her as she would not have believed the results. She went on to say that she thought many other 
people would feel the same way in the absence of an affected family member. A study on the 
beliefs of African-American women on SCD carrier screening found that while participants 
believed SCD to be a severe disease, and saw the benefits of screening, they believed themselves 
to be at sufficiently low risk to not need such a test (Gustafson et al., 2007). While not entirely 
similar to the participant described above, it does indicate a shared belief in their own 
improbability to be a carrier of SCD.  
5.2.2 Neonatal screening 
Most participants (n=12) approved of the idea of neonatal screening, while indicating that 
parental permission would need to be obtained before testing the child. In many newborn 
screening programs, this is not done, as babies are tested for SCD as part of a routine newborn 
genetic screen. It was generally believed that early knowledge of diagnosis could possibly 
benefit the child in question, or at least give parents warning of the disease before the child 
would become seriously ill: 
P12F: “I think it is a good idea, because you will know from 
day one. It will be an advantage to know before it’s too late, 
like we did.” 
The value of knowledge, opportunity to prepare appropriate care, and possibility of early 
treatment have previously been reported as perceived benefits of neonatal screening for genetic 
conditions, including SCD (Long et al., 2011). 
The few that disagreed with this form of screening felt that it was ‘too late’ if the child was 
already born for testing to be beneficial or that testing without any physical indications would be 
a sign of ‘negative thinking’.  
5.2.3 Prenatal diagnosis 
The majority of the participants in this study (n=14) supported the idea of PND. In fact, two 
participants had undergone PND themselves, one in Cape Town due to a previous child being 
affected with SCD, and one in the UK, apparently as a result of ethnic-based screening in an 
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obstetric setting.  However, both participants seemed to be somewhat unclear on what they had 
consented to when accepting the test. Participant P1F, who had the prenatal test in Cape Town, 
could not recall why an amniocentesis was done, and said only that she was told to do it by 
doctors. As this test is always offered as the choice of the woman in question and informed and 
signed consent is compulsive before the invasive obstetric procedure, this is unlikely to be the 
case. This participant’s confusion about the test she had done highlights the importance of 
comprehensive pre-test counselling. The participant did however remember that the test showed 
her child would not be sick, which is perhaps the most important part.  
Participant P2F, who was tested in the UK, had a similar experience, although she emphasised 
the value of a prenatal test. 
“I agreed to everything. Yes, yes, yes. To be honest I was 
nervous and I just say yes. So I did what they were asking me 
and… There’s nothing wrong with that you know. Because if 
they didn’t do the test, I would have had no idea he had sickle 
cell. What they did was good because now I know what to 
prepare myself for.” 
Although this participant said that she agreed to be tested mostly because of the anxiety at her 
‘first time in a different country’, she ultimately derived value from the test as it allowed her to 
prepare herself, both mentally and practically, for a child affected with SCD. 
This opportunity to prepare oneself was in fact the reason for most participants’ support of PND 
who felt it would be valuable to be forewarned if a child would be affected. The value of 
awareness was previously reported on by Long et al. (2011), who found that the information 
provided by a prenatal test was believed to ultimately benefit the pregnancy, the mother, or the 
family. 
Of the participants who did not support PND, one cited the risk involved in the test. In all 
methods of invasive prenatal testing there is a small but significant risk of miscarriage (0.5-2%) 
(Harper, 2010). This risk was perceived as too great by participant P4M when the test was 




Another participant disagreed with prenatal testing as she felt the outcome would not be 
actionable:  
P3F: “I was asked that question before I was even pregnant 
with this one. I asked them what’s the reason behind that. Is it 
that you can stop it (SCD)? They say no, you can never stop it, 
it is just to ask you if you would be concerned in terminating 
the pregnancy. So I told them I would never do such a thing.” 
Most participants shared this attitude toward the termination of a pregnancy affected with SCD, 
and would seemingly do a PND simply for the information it provided, the opportunity to 
prepare, and the resulting peace of mind. Few (n=4) would consider the possibility of a medical 
abortion.  
In almost all cases this attitude towards termination was founded on religious principles. Even 
participant P2F, the only non-religious participant in the group, disagreed with termination for 
moral reasons, as shown by her response, when offered termination following a positive PND: 
P2F: “Why stop the pregnancy? I can, you know, I felt him. 
He was here, he’s still alive. He’s still got all his hands and 
everything. And there’s a reason why I got a sickle cell child. 
Why I want to stop it? It’s a living body there.” 
On the other hand, there were a few participants that thought medical termination of pregnancy 
would be justified, considering the severity of SCD. This is shown in the following answers 
given by participants to the question of what they thought of medical abortion: 
P17F: “This is better. It’s something you didn’t see, it’s better 
than something you see, so painful. You’re pregnant with this 
inside, if this pregnancy is not nice you can know, you can 
take it out. It is better than to leave someone and at nine 
months it is out and the baby’s sick. When you see the baby, 
it’s not so easy.” 
P16F: “Which is good. Which is good, actually. It’s not a 
good condition to have a child having that for the rest of their 
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life. But it is better to prevent it. Stopping it would be good. 
That’s according to me though.”  
The first quote is the participant’s explanation of how much harder it is to raise a child affected 
with SCD versus terminating the pregnancy before ‘seeing’ that child. The second quote, by 
participant P16F, presented much the same view, although her last sentence highlighted a very 
important point. She conceded that not everyone would share her opinion and in doing so 
allowed for a universal truth around medical termination. In the case of such a highly personal 
decision, influenced by many factors (from religion to personal experience), it is essential to 
realise that there is no correct decision. The role of the genetic counsellor is simply to offer the 
choice and then provide support where possible and appropriate.  
Intriguingly, participant P16F had based her feeling on termination of pregnancy due to severity, 
and all prevention of SCD, not on her experience with her affected child, but on her previous 
knowledge of the disease. At the time of her interview, her child had been recently diagnosed 
and generally in good health. As a result she had experienced only minimal burdens of raising a 
child affected with SCD. However, she had knowledge of SCD from DRC, and this possibly led 
to her strong feelings in favour of prevention. Her attitude may also have been influenced by 
lingering shock at the diagnosis and fear of the future. Participant P6M was ambivalent, saying 
that at this time he did not know how he felt about the termination of an affected pregnancy. He 
could find merit in arguments made both for and against it and was unsure what he would do if 
faced with such a situation. 
Recent studies done in Cameroon reported 40.9 and 62.5% acceptance of the principle of 
termination of a SCD affected pregnancy among patients and parents, respectively (Wonkam, de 
Vries, et al., 2014; Wonkam et al., 2011). This is considerably higher than the 23.5% found in 
this study, despite the fact that religious affiliation, the main reason for disagreeing with 
termination in this study, was equally high in all study groups. The difference in opinions could 
possibly be accounted for by another variable, difference in disease burden. With carrier 
frequencies ranging from 8-34% and no medical health insurance coverage (Wonkam et al., 
2011), SCD burden is considerably worse than in SA. 
5.3 Genetic counselling 
Genetic counselling, as defined by Genetic Counsellors of SA, is a medical service that provides 
information about genetics, helps individuals understand the impact of a genetic diagnosis on 
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their life, and assists individuals with making informed personal and medical decisions 
(www.geneticcounselling.co.za). 
Parents from the RCWMCH Haematology service can be referred for genetic counselling at the 
discretion of the doctor at any time, although it is most often done following a new diagnosis. In 
recent years, when possible and the number of genetic counsellors allow it, a counsellor has been 
available during Haematology clinic hours for any new patients, those who had never had 
genetic counselling, or those the doctors felt would benefit from it. Nevertheless, not all patients 
are seen by a genetic counsellor and those who are, are typically seen only once unless another 
session is requested by the counsellor, parent, or doctor. During genetic counselling sessions the 
counsellors usually discuss the cause of SCD, autosomal recessive inheritance, and the 
implications thereof and risk to other and/or future children. Further topics may be covered on a 
needs basis as indicated by the parent during the session. Sessions are on average 45 minutes 
long. 
Records of genetic counselling sessions are kept in patient folders at RCWMCH Haematology 
clinic, and these folders were examined in order to determine which participants had received 
counselling, when that counselling had occurred, and who had attended the session. 
5.3.1 Influence of genetic counselling on knowledge of Sickle Cell Disease 
Several of the participants (n=8) had had genetic counselling before being interviewed for this 
study. All sessions took place between 2007 and 2011, with the exception of participant P7M. 
Participant P7M received counselling immediately before being interviewed. No amount of time 
had passed, so it was impossible to ascertain how well he had retained the information discussed 
during the session. Furthermore, he did not directly answer any questions asked about cause or 
inheritance of SCD. Instead, he referred to a sheet of paper given to him by the counsellor. For 
these reasons, P7M is not included in the following discussion. 
All participants were asked if they had ever received genetic counselling, to which only three 
(P9M, P12F and P17F) responded in the positive. Remaining participants replied negatively or 
said that they could not remember. Mostly, those who had had counselling, could not recall it 
during the interview. This can be due to the time passing because in even the most recent cases it 
had been approximately four years since the genetic counselling session had taken place. 
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Another explanation for this lack of recall could be the fact that genetic counselling is not yet 
well known to parents and participants might not have remembered it as something distinct from 
a routine doctors’ visit.  
In discussing the participants’ knowledge on SCD, including its cause and inheritance pattern, it 
is important to take into account which participants had had genetic counselling prior to being 
interviewed, and what the influence of that counselling was on the level of knowledge.  
If the success of the genetic counselling session, for the purpose of this discussion, is seen as 
ability to recall information provided, success varied greatly between participants.  As illustrated 
by the following quote, participant P6M benefited greatly from the genetic counselling session in 
terms of understanding the disease, despite the fact that he could not recall having a session: 
“It is a genetical disease, inherited genetical disease, that 
causes change of the red blood cells in my son’s body……The 
abnormal function of the red blood cells, sometimes, the 
haemoglobin is low and it gets stuck into the body.” 
This knowledge was in turn used to inform the child’s preschool and certain family members of 
exactly what was going on. The preschool was concerned that the child might be contagious, but 
was reassured by the information given to them by P6M. This is a good practical example of 
how knowledge can benefit the affected child.  
Another example of the benefit of genetic counselling was illustrated by participant P9M. He 
explained that upon first hearing the diagnosis, he did not believe it to be true. This belief was 
the result of his affected child not looking the way he believed a child affected with SCD should 
look. However, after the genetic counselling he said he ‘could understand everything’ and had 
accepted the diagnosis. Genetic counselling had helped him overcome some emotional 
difficulties related to dealing with his child’s diagnosis. 
5.3.2 Further counselling needs 
Even among participants who had previously received genetic counselling, there were 
indications of a need for more counselling. Consider the following quotation: 
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P17F: “Or maybe I, with this one, I suspect, maybe I take… I 
move too much when pregnant. So it (SCD) comes. It’s not 
nice for me. I mean suddenly I think…” 
Despite having been counselled on the cause of SCD, participant P17F still had some 
reservations about possibly causing her child’s illness. Referrals to the genetic counsellor are 
most commonly made following a new diagnosis, at which time parents are often overwhelmed 
by not only new information, but also the emotions associated with it (Atkin et al., 1998). And 
while genetic counselling is undeniably important in order to give and explain relevant 
information at that crucial time, it is hardly surprising that parents do not recall all the details. 
Follow up sessions could help with retaining information, while also giving parents an 
opportunity to ask questions after having had some time to think about it.  
Of the participants that had not received counselling, two were able to provide reasons. P4M 
explained that he did not often bring his children to clinic, and as such had not really had the 
chance to accompany his wife to a genetic counselling session. This is something he seems to 
regret and almost resent, as illustrated by the following quote: 
P4M: “I’m sorry I don’t understand the point for this 
sickness, because I need like someone to explain it or to show 
me what is that cause. They just only give me the few sentence, 
they don’t even go through and show me what is the real 
cause of that sickness. I never even get a chance to speak to 
the counsellor, only my wife who always get a chance.” 
When asked what his wife had told him about the information discussed during her genetic 
counselling session, he responded that she could not really explain it. It is very rare that a couple 
comes to the clinic together, as the clinic takes place during work hours. Most commonly, one or 
of the parents, or even a third party, will accompany the child to the clinic. Under these 
circumstances, it is understandable that often only one parent will be seen by a genetic 
counsellor. 
However, practices can be put in place to ensure the spouse or partner receives as much 
information as possible. For example, the genetic counsellors have developed a SCD information 
sheet that briefly covers topics like inheritance and cause. This is given to parents on a need 
basis, but should perhaps become routine practice. Then, even if the parent that is seen 
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understands everything discussed, the information sheet can serve as a memory aid when 
explaining what was discussed during the session to their partner. Or in cases where the absent 
parent might be the one with clearer understanding, the information sheet can give them the 
knowledge they need and might have been unable to acquire otherwise. 
Participant P14F had an almost contrasting reason for not receiving counselling, she did not 
want to. She felt that seeing a genetic counsellor would be too much for her to handle. She had 
never seen a genetic counsellor, and as she was very emotional in the interview, she was asked if 
she would be like to be referred to a counsellor. Her answer is given here: 
“Sometimes I don’t want to talk. When someone asks me I 
don’t want to. It gives me stress.” 
This was very illuminating, as it points to a misunderstanding of what a genetic counsellor is. 
While it is true that genetic counsellors offer emotional support, their main role would be 
providing information and identifying possible areas of concern. Participant P14F did not seem 
adverse to receiving information, but she was opposed to being forced to talk about her child 
being ill. She felt it would add to her stress and not improve anything. In fact, she did not want 
to see a counsellor, and failed to realise that a counsellor and genetic counsellor offer different 
services. 
This participant, and others who expressed similar feelings, could benefit from a number of 
genetic counselling sessions, instead of only one as is routine. This will give them time to 
process and come to terms with all the information. It will also be beneficial if a relationship of 
trust is built between them and the counsellor in order to optimise the way they receive the 
information. It will allow the counsellor the freedom to not give all the information in one 
session. In this way the first session could, for example, focus only on explaining autosomal 
recessive inheritance, and how it might have happened that SCD has never been found in the 
family before. Another session can focus on explaining the diagnosis, tests, and prognosis, if 
necessary, and also discussing treatment.  
All these things could help parents come to terms with the diagnosis, which will in turn have a 
positive impact on the entire family. This will also place the genetic counsellor in a position to 
assess if and when psychological intervention might be justified, and then make the necessary 
referrals.   
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Several participants who had not previously received genetic counselling were referred after 
their interview as they expressed a wish for more information on SCD. 
5.4 Chapter summary 
This chapter discussed participants’ views on screening for SCD as well as their experience with 
genetic counselling. Overall, the majority of participants supported all methods of screening for 
SCD, even in instances where participants would not make use of specific services, they agreed 
that it should be available to those who chose to utilise it. Despite the severity of the condition, 
most participants stated that they would not consider terminating an affected pregnancy, based 
on religious principles. These findings are visually presented in Figure 5.1. While most 
participants had never received genetic counselling, some of those who did revealed increased 
knowledge and acceptance of SCD. However, there is indication for improvement of this 
service, the most valuable of which could be offering follow-up sessions to all parents.  
 






Chapter 6: Conclusions, limitations and recommendations 
6.1 Conclusion 
This study aimed to explore the experiences of parents with children affected by SCD in Cape 
Town, and discover how those experiences were shaped by knowledge of SCD and the 
perceived burdens of care, as well as assessing opportunities for improving genetic counselling 
services. In addition the study aimed to explore parent’s attitude to preventive policies aimed at 
reducing the prevalence of SCD. Seventeen biological parents with a child affected with SCD 
were interviewed. Recordings were transcribed for thematic content analysis. 
The level of SCD specific knowledge varied among the participants, ranging from no knowledge 
at all to being aware it is a genetic blood disorder. Many participants revealed a 
misunderstanding of mode of inheritance of SCD, with many basing their deductions of 
inheritance on prior knowledge of the disease. Prior knowledge also greatly influenced 
participants’ expectations of life expectancy, although their expectations were not always 
concordant with the expectancies in SA. 
It was found that participants experienced several burdens in raising an affected child. While 
some burdens had certain practical, everyday consequences, such as time and finance, others 
were more psychosocial in nature, such as lack of support as a result of immigration, and 
required managing on a more psychological level. The strategies employed by participants for 
this management were also explored, underlining certain strengths and weaknesses thereof. 
It was found that the majority of participants supported all methods of screening for SCD. Even 
in instances where the participants indicated that they would not make use of specific services 
themselves, they agreed that it should be available to those who chose to utilise it, provided it 
remained the individual’s choice. Lastly, while many participants had never received genetic 
counselling, benefits to those who had included increased knowledge and understanding of SCD 
and better acceptance thereof. There is a strong indication for the need of the improvement of 
genetic counselling services available to parents of children affected with SCD. The researcher 
feels that, ideally, parents of all SCD affected children should be seen by a genetic counsellor at 
least twice, once following the diagnosis and once, after a period of time has elapsed, to assess 
understanding and any psychosocial needs. Additionally, genetic counsellors should be available 
for follow-up referrals from doctors at all times. The genetic counselling services at RCWMCH 
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Haematology clinic is not currently this involved, mainly as a result of the few genetic 
counsellors available.   
The research findings of this study have provided valuable insights, not only around the 
experiences of parents, but also about the genetic counselling services provided and their 
potential role. But the findings of this study cannot be generalised to all parents of children with 
SCD in SA, and as such more research is needed. It is hoped that the observations noted in this 
study, combined with the recommendations made will assist in providing more informed genetic 
services to those seen at the Haematology clinic. The researcher feels that this study could 
contribute towards improving understanding and subsequent care of individuals raising a child 
affected with Sickle Cell Disease. 
6.2 Study limitations 
 Due to limitations on the time available to conduct interviews and the time consuming 
nature of transcribing the interviews, analysis of the data was only started once all 
interviews were finished. This meant that any theories emerging from the first 
interviews could not be explored in subsequent interviews.  
 
 The main purpose of this project was to provide the researcher with a learning 
experience to become skilled in qualitative research, which meant there was a distinct 
learning curve. Consequently the first few interviews conducted were not as good and 
insightful as the latter interviews, when the researcher had gained more experience. 
 
 All interviews were conducted in English because of time and resource constraints. As 
this was not the primary language or mother tongue of most of the research participants 
it may have affected the quality of data gathered. 
 
 Due to time constraints not many more interviews could be conducted. However, it was 
felt that saturation was reached as similar data was emerging from all interviews and the 
last few interviews did not lead to new insights. 
 
 The purposeful sampling method used in this study has the potential to lead to some 
ascertainment bias, as the views and experiences of individuals who are unwilling to 
participate or less communicative are not included. 
75 
 
6.3 Practical implications and recommendations  
Based on the findings of this study, the following recommendations are made. Firstly, improved 
communication and co-ordination between the Haematology and Genetic units at RCWMCH 
could be advantageous to ensure early referrals to genetic counselling services for parents with a 
newly diagnosed child or those who had never received counselling. In addition, follow-up 
appointments would be beneficial to parents who are not yet able to cope with their child’s 
diagnosis. This would ensure all patients fully benefit from genetic counselling services. 
Secondly, a simple fact sheet explaining the condition, its cause and inheritance should be given 
to all parents seen at RCWMCH Haematology clinic.  Such a fact sheet is already available 
through the University of Cape Town Human Genetics website, and the routine distribution 
thereof may be helpful in correcting misconceptions as well as providing something that can be 
easily shared with family or referred to in future. The translation of this factsheet into other 
languages, such as French, could further improve the reach of this fact sheet. A similar factsheet, 
focusing on more medical aspects of SCD, is currently accessible at the clinic although not 
actively distributed. This fact sheet could also be distributed to primary health care 
professionals, ensuring all are well informed and aware of the condition. 
It is also recommended that, although genetic counsellors routinely enquire about parents’ prior 
knowledge of the disease in question, it might be prudent to pay extra attention to it in this group 
of patients, given that they often do have prior knowledge of SCD, possibly under a different 
name. It might be necessary to correct certain misunderstandings or explain some aspect in more 
detail as a result of what comes to light about prior knowledge. 
It would also be very beneficial if both parents of an affected child are seen by a genetic 
counsellor once during their child’s treatment at RCWMCH. This would guarantee both parents 
the chance to ask questions as well as ensuring information held by both parties are correct. 
While genetic counselling services at RCWMCH are mainly aimed at parents, the young 
adolescent patients with SCD could equally benefit from it. As such, it might be valuable for 
doctors to also start referring their patients who are of a certain age for genetic counselling, 
instead of only referring parents. 
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The founding of a support group for parents of children affected with SCD could provide parents 
access to a much needed resource for social support. Exposure to others in the same situation 
could be advantageous by providing not only hope, but also a space where 
stories/advice/experiences can be shared. 
Lastly, to ensure that parents and patients fully benefit from genetic counselling services, a 
checklist can be developed, to be implemented with every new diagnosis of SCD and marked of 
as completed. This list would serve as a reminder and could include a specific number of genetic 
counselling sessions at certain intervals, a session including both parents, child’s genetic 
counselling session (if applicable) and a reminder to provide information sheet and details of 
support group. 
6.4 Research recommendations  
Further research is needed to quantify the level of knowledge parents have of SCD, how that 
knowledge is influenced by genetic counselling, and how well it is retained after a period of 
time. This will be more generelisable and give a clear indication of which areas of knowledge 
are most difficult to address. Conducting research into the experiences of parents of affected 
children in other South African settings would be also be valuable, as it might differ according to 
availability of services, the quality thereof or other variables. 
An investigation into the knowledge of SCD among primary health care workers would assist in 
determining the need for increased education and advocacy regarding the diseases. These 
workers could often be involved in either correctly referring the patient when first presenting 
with symptoms or treating them during a pain crisis, and as such it is important that they are 
cognisant of the disorder. 
Finally, it would be of great value to explore the knowledge and experiences of SCD among 
individuals who are affected themselves, possibly both as adolescents and adults, in order to 
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Appendices 
Appendix I: Information sheet 
Study title: Knowledge and experiences of parents with children affected by Sickle Cell Disease 
in Cape Town. 
Student researcher: Katryn van Niekerk 
katrynfourie87@gmail.com  076 481 6501 
Supervisor: Prof. Ambroise Wonkam 
     ambroise.wonkam@uct.ac.za        021 406 6307 
Co-supervisors: Dr. Jantina de Vries 
jantina.devries@uct.ac.za           021 650 5716 
Nakita Laing 
n.verkijk@uct.ac.za           021 406 6373   
Introduction and Summary 
We would like to ask you to participate in a research study that aims to investigate the 
knowledge, experience and needs of parents caring for children affected with SCD. The study 
has been initiated through the Division of Human Genetics, University of Cape Town. The 
findings of this study will facilitate the identification of areas where health services available to 
parents of children with SCD could be improved, with a specific focus on the genetic 
counselling services that are offered. This study is the focus of a minor dissertation for 
completion of an MSc Genetic Counselling degree. 
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If you agree to participate I would like to talk to you about your experiences with caring for your 
child with SCD as well as your understanding of the disorder. The discussion may take up to an 
hour and will be recorded. The interview will be anonymised through the use of codes, but 
excerpts from the interview may be used in reporting on this study. 
A possible risk to you will be the discussion of sensitive and emotional topics during the 
interview. If you become distressed during the interview you will be referred to a practiced 
Genetic Counsellor registered with the Health Professional Council of South Africa. Any 
actionable comments revealed during your interview will be acted upon. 
While you will receive no immediate benefit from this study, long term benefit will be to, if 
necessary, improve the genetic counselling process and services provided. 
Privacy 
All information will be handled confidentially and everything you say will be kept private. Only 
the researcher will know your name and any discussion with the project supervisors will make 
use of an assigned study code only.  
The interview will be audio recorded so that the researcher does not have to write much during 
the interview. The recording will be kept locked up until the research has been written up and 
will then be destroyed immediately. The data stored on the computer will have a code only and 
your name will not appear anywhere. 
Access to the recorded interview as well as transcripts will be limited to the researcher, being 
kept either in a locked drawer or on a password protected computer. Information may be used 
for a thesis, publications in scientific journals and presentations at professional congresses, but 
names will not be included.  
Additional Information
Your participation in this study is entirely voluntary. You can withdraw your participation at any 
point. The interview can be terminated at any time and the recording will then be destroyed. 
Withdrawing from the study will not in any way negatively affect your future access to medical 
and genetic services for your child. 
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 Should you have any questions during the duration of this study regarding: 
1. problems as a result of the research, or
2. questions regarding information about the project
please contact me or one of my supervisors (details at start of document). 
If you have any questions about your rights as a research participant please contact Prof. M 
Blockman, Chair of the University of Cape Town Faculty of Health Sciences Human Research 
Ethics Committee on (021) 406-6496. 
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Appendix II: Interview schedule 
Participant number………………. 
Sociodemographic information 
Age  Country of origin 
Marital status  Number of children 
Religious affiliation Number of affected children 
Level of education 
Knowledge and understanding of SCD 
What is SCD called in your native language 
Causes 
Inheritance (Father, mother, both) 
Main presentations 
Treatment 
Have you ever had genetic counselling 
Experiences 
What is the hardest thing about raising a child with SCD 
Disease symptoms 
Hospital services 
Economical (impact on family finance, days of work lost etc.) 
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Familial, relationship and society 






Attitude to TOP and reason 
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Appendix III: Informed consent form 
PARTICIPANT CONSENT FORM 
1. I have been invited to participate in the above research project because I have a child
affected by SCD.
2.1 I have been provided with sufficient information and understand that the objective of  
this study is to investigate: 
 The knowledge and understanding of SCD among parents of affected children
 The impact of having a child affected with SCD, and my experiences in this regard
 The genetic counselling services provided to my child and my perception of it
 The attitude among parents of SCD affected children toward preventative policies
2.2 I understand that some of the questions may make me angry or sad. The researcher     
will refer me to a genetic counsellor if necessary. She will show me respect, acceptance        
and empathy during the interview. 
3.1 I have been assured that all information will be handled confidentially. 
3.2 I understand that the interview will be tape recorded so that the researcher does not have 
to write much during the interview. 
4. I have been assured that the recorded and transcribed information discussed during the
interview will only be made available to the researcher’s supervisors with my study
code number and that they do not know that it refers to my name.
5. I willingly agree to consent in taking part in the study and I have been informed that I
may refuse to participate in this project and that I may stop participating at any stage.
6. …………………………………………. has explained the information of the study to
me in English. I am proficient in that language and my questions have been answered 
satisfactorily. 
7. I understand that there will be no medical benefits to me from this study.
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8. I have been assured that participation in this project will not lead to additional costs for
me or my family and I will not benefit from it financially.
I HEREBY DECLARE THAT I HAVE VOLUNTARILY AGREED TO PARTICIPATE 
IN THE ABOVE RESEARCH STUDY AND THAT I AGREE TO HAVE MY 
INTERVIEW AUDIO RECORDED 
Signed at…………………………………………………… on……………………..2015 
………………………………… ...........………………………. 
Participant’s signature             Witness 
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Appendix IV: Ethics approval documentation 
signature removed
